https://www.tempus.com/news/do-we-have-the-technology-to-cure-pancreatic-cancer/ 2021-12-14T23:40:32+00:00 https://www.tempus.com/news/smoking-has-a-very-broad-long-lasting-impact-on-the-human-genome/ 2021-12-14T23:40:33+00:00 https://www.tempus.com/news/pr/tempus-signs-strategic-collaboration-agreement-with-astrazeneca-to-advance-oncology-therapeutics/ 2021-12-29T05:07:35+00:00 https://www.tempus.com/news/pr/tempus-announces-the-appointment-of-nobel-laureate-and-crispr-co-inventor-dr-jennifer-doudna-to-its-board-of-directors/ 2021-12-29T05:09:03+00:00 https://www.tempus.com/news/pr/tempus-unveils-a-breakthrough-in-ai-for-oncologists-tempus-one/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/tempus-and-yale-announce-research-collaboration-to-accelerate-covid-19-test-development/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/tempus-announces-glioblastoma-data-offering-in-collaboration-with-asco/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/clinical-breast-cancer-study-reveals-that-tempus-real-world-database-mirrors-overall-u-s-breast-cancer-population/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/tempus-expands-licensing-agreement-with-bristol-myers-squibb-to-analyze-and-discover-rna-based-targets/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/tempus-announces-200-million-series-g-2-financing/ 2021-12-29T05:09:04+00:00 https://www.tempus.com/news/pr/tempus-announces-100-million-in-series-g-financing/ 2021-12-29T05:09:31+00:00 https://www.tempus.com/news/pr/tempus-announces-expansion-into-infectious-diseases-starting-with-covid-19/ 2021-12-29T05:09:31+00:00 https://www.tempus.com/news/pr/tempus-launches-covid-19-specific-clinical-and-research-initiatives-for-oncology/ 2021-12-29T05:09:31+00:00 https://www.tempus.com/news/pr/tempus-announces-the-appointment-of-scott-gottlieb-md-to-its-board-of-directors/ 2021-12-29T05:09:32+00:00 https://www.tempus.com/news/pr/genmab-and-tempus-enter-into-strategic-collaboration-agreement/ 2021-12-29T05:09:32+00:00 https://www.tempus.com/news/pr/geisinger-and-tempus-announce-collaboration-to-develop-cardiology-diagnostic-and-prognostic-tools-using-artificial-intelligence/ 2021-12-29T05:09:32+00:00 https://www.tempus.com/news/pr/tempus-expands-its-management-team-with-the-appointment-of-lauren-silvis-as-senior-vice-president-of-external-affairs/ 2021-12-29T05:09:32+00:00 https://www.tempus.com/news/pr/dr-arul-chinnaiyan-joins-tempus-as-scientific-adviser/ 2021-12-29T05:10:16+00:00 https://www.tempus.com/news/pr/dr-kevin-white-joins-tempus-as-president/ 2021-12-29T05:10:33+00:00 https://www.tempus.com/news/pr/study-confirms-that-americans-neglected-their-healthcare-during-covid-19-pandemic/ 2021-12-29T05:12:21+00:00 https://www.tempus.com/wp-content/uploads/2021/04/1-access-to-health-care-statistics.png https://www.tempus.com/wp-content/uploads/2021/04/2-neglected-health-care-statistics-.png https://www.tempus.com/wp-content/uploads/2021/04/3-cost-of-health-care-statistics.png https://www.tempus.com/wp-content/uploads/2021/04/4-preventative-health-screening-statistics.png https://www.tempus.com/publications/real-world-characteristics-and-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-ansclc-receiving-immune-checkpoint-inhibitor/ 2022-01-25T19:23:08+00:00 https://www.tempus.com/publications/real-world-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-ansclc-and-autoimmune-disease-ad-receiving-immune-checkpoint-inhibitors-icis/ 2022-01-25T19:23:08+00:00 https://www.tempus.com/publications/transcriptome-based-cancer-type-prediction-for-tumors-of-unknown-origin/ 2022-01-25T19:23:08+00:00 https://www.tempus.com/news/pr/fda-grants-breakthrough-device-designation-to-tempus-atrial-fibrillation-ecg-analysis-platform-developed-in-collaboration-with-geisinger/ 2022-01-26T16:20:53+00:00 https://www.tempus.com/news/pr/tempus-and-labcorp-announce-collaboration-to-accelerate-clinical-trial-patient-participation/ 2022-01-26T16:20:53+00:00 https://www.tempus.com/news/pr/researchers-find-ai-can-predict-new-atrial-fibrillation-stroke-risk/ 2022-01-26T16:20:53+00:00 https://www.tempus.com/news/pr/tempus-announces-the-addition-of-dr-kimberly-blackwell-as-chief-medical-officer-and-dr-kenneth-carson-as-vice-president-of-clinical-solutions/ 2022-01-26T16:20:53+00:00 https://www.tempus.com/news/pr/tempus-submits-pma-application-to-the-fda-for-its-xt-onco-assay/ 2022-01-26T16:20:54+00:00 https://www.tempus.com/news/pr/tempus-announces-strategic-collaboration-with-janssen-applying-data-science-to-enhance-therapeutic-development/ 2022-01-26T16:20:54+00:00 https://www.tempus.com/news/pr/molecular-twin-initiative-will-help-advance-precision-cancer-treatment/ 2022-01-26T16:20:54+00:00 https://www.tempus.com/news/pr/new-genomics-technology-puts-precision-oncology-into-practice-at-rush/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-unveils-ai-enabled-smart-tests-across-disease-types/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-opens-sequencing-lab/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-and-precision-health-informatics-announce-precision-medicine-collaboration/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-and-penns-abramson-cancer-center-expand-genomic-collaboration/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-announces-the-addition-of-ari-caroline-and-iker-huerga-to-its-leadership-team/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-selected-as-sequencing-and-analytics-provider-by-the-prostate-cancer-clinical-trials-consortium-forphase-ii-clinical-trial/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-launches-tempus-xe-whole-exome-sequencing-to-empower-data-driven-cancer-care-and-research/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-accelerates-its-ehr-integration-scope-with-epic/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-launches-new-mobile-app-to-make-clinical-and-genomic-data-more-accessible-to-physicians-at-the-point-of-care/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/community-health-network-collaborates-with-tempus-to-personalize-cancer-care-improve-patient-health-through-genomics-testing/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/bayer-and-tempus-initiate-collaboration-to-advance-patient-access-to-genomic-testing-and-precision-medicine/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-launches-prospective-priority-research-study-and-increases-support-for-oncology-research-initiatives-despite-pandemic-challenges/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-time-trial-program-reaches-critical-scale-and-operational-milestones/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/wp-content/uploads/2020/05/Day-14-Timeline.png https://www.tempus.com/news/pr/tempus-expands-leadership-team-with-the-appointment-of-joel-dudley-phd-as-senior-vice-president-of-research/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-and-leidos-biomedical-research-inc-launch-effort-to-enhance-the-cancer-genome-atlas/ 2022-01-26T16:21:30+00:00 https://www.tempus.com/news/pr/tempus-and-sanford-health-collaborate-on-personalized-medicine-initiative/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-latest-immunotherapy-project/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/cancerlinq-engages-leading-technology-companies-tempus-and-precision-healthai-to-accelerate-data-driven-insights-to-oncologists-and-the-cancer-care-community/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-and-vanderbilt-ingram-cancer-center-announce-data-initiative-to-improve-outcomes-for-cancer-patients/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/hello-world/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/wp-content/uploads/2018/05/news-logo.png https://www.tempus.com/news/pr/tempus-and-the-parker-institute-for-cancer-immunotherapy-work-together-to-analyze-data-to-help-inform-immunotherapy-treatments/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-additional-80-million-in-financing/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-new-initiative-to-support-physicians-efforts-to-deliver-personalized-medicine/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-to-collaborate-with-cancerlinq-llc-and-u-s-food-and-drug-administration-on-checkpoint-inhibitors/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-110-million-in-series-e-financing/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-and-mary-crowley-cancer-research-launch-a-new-lung-cancer-initiative/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/wp-content/uploads/2018/10/MC-LOGO-2015-with-TM-FINAL.jpg https://www.tempus.com/news/pr/tempus-announces-next-phase-of-biological-modeling-efforts/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/asco-and-tempus-announce-collaboration-to-help-research-sites-identify-potential-participants-for-the-targeted-agent-and-profiling-utilization-tapur-study/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-and-huntsman-cancer-institute-at-the-university-of-utah-partnering-on-pancreatic-cancer-research-initiative/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-and-feist-weiller-cancer-center-at-lsu-health-shreveport-announce-brain-cancer-research-collaboration/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-200-million-in-series-f-financing/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-announces-time-trial-service-a-new-integrated-molecular-evaluation-that-leverages-artificial-intelligence-to-rapidly-match-cancer-patients-to-clinical-trials/ 2022-01-26T16:21:31+00:00 https://www.tempus.com/news/pr/tempus-and-northwesterns-lurie-cancer-center-announce-personalized-medicine-partnership-for-cancer-patients/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-selected-by-pancreatic-cancer-action-network-as-partner-for-new-personalized-medicine-initiative/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-rush-university-medical-center-announce-personalized-medicine-partnership/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/dr-gary-palmer-joins-tempus-as-chief-medical-officer/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-teams-with-major-academic-medical-center-to-advance-treatment-options-for-patients-diagnosed-with-aggressive-brain-cancer/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/erik-phelps-joins-tempus-as-executive-vice-president-and-general-counsel/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-announces-brca-focused-initiative-in-partnership-with-penns-basser-center-for-brca/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-northwestern-expand-partnership-to-accelerate-personalized-medicine-efforts/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-northwestern-expand-partnership-to-accelerate-personalized-medicine-efforts-2/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/dr-andrea-califano-joins-tempus-scientific-advisory-board-and-tempus-and-darwinhealth-partner-on-research-initiative/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-university-of-chicago-medicine-collaborate-on-pancreatic-cancer-research-project/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-to-assist-university-of-california-san-diego-in-personalizedmedicine-initiative/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-rush-university-medical-center-partnering-to-expand-hospitals-first-biobank/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-university-of-california-davis-comprehensive-cancer-center-announce-personalized-medicine-partnership-for-cancer-patients/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-cleveland-clinic-collaborate-on-personalized-medicine-initiative/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-announces-130m-raised/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-and-the-ohsu-knight-cancer-institute-collaborating-on-personalized-medicine-data-initiative/ 2022-01-26T16:21:32+00:00 https://www.tempus.com/news/pr/tempus-announces-the-acquisition-of-akesogen/ 2022-01-26T16:21:33+00:00 https://www.tempus.com/news/pr/tempus-announces-new-subscription-service-for-pharma-biotech-and-academic-researchers/ 2022-01-26T16:21:33+00:00 https://www.tempus.com/news/pr/tempus-and-university-hospitals-seidman-cancer-center-announce-joint-effort-to-customize-treatment-for-cancer-patients/ 2022-01-26T16:21:59+00:00 https://www.tempus.com/news/pr/tempus-announces-christopher-mason-phd-joins-as-vice-president-of-emerging-genome-technology/ 2022-01-26T16:21:59+00:00 https://www.tempus.com/news/pr/tempus-announces-leadership-team-expansion-including-chief-commercial-officer-and-chief-financial-officer/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/tempus-announces-abdul-hamid-halabi-as-senior-vice-president-of-data-products/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/tempus-unveils-tempus-o-a-platform-to-structure-and-annotate-clinical-data-at-scale/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/cvs-health-launches-transform-oncology-care-program-to-help-improve-patient-outcomes-and-lower-overall-costs/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/tempus-launches-covid-19-test-with-at-home-sample-collection-and-covid-19-next-generation-sequencing/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/leading-real-world-data-and-analytics-organizations-form-industry-coalition-to-advance-policies-to-support-regulatory-use-of-real-world-evidence/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/tempus-unveils-its-lens-platform-offering-unparalleled-access-to-one-of-the-worlds-largest-de-identified-clinical-and-molecular-datasets/ 2022-01-26T16:22:22+00:00 https://www.tempus.com/news/pr/tempus-and-university-of-michigan-announce-partnership-for-cancer-patients/ 2022-01-26T16:22:37+00:00 https://www.tempus.com/news/pr/tempus-announces-new-genomic-sequencing-lab-in-research-triangle-park-in-durham-nc/ 2022-01-26T16:22:37+00:00 https://www.tempus.com/news/pr/tempus-announces-prospective-psychiatric-study/ 2022-01-26T16:22:37+00:00 https://www.tempus.com/news/pr/tempus-announces-eleven-abstracts-accepted-for-presentation-at-the-2021-american-society-of-clinical-oncology-annual-meeting/ 2022-01-26T16:22:37+00:00 https://www.tempus.com/news/pr/tempus-adds-tempus-xf-a-liquid-biopsy-assay-to-sequencing-capabilities/ 2022-01-26T16:22:51+00:00 https://www.tempus.com/news/pr/tempus-announces-abstracts-to-be-presented-at-the-american-association-of-cancer-research-annual-meeting-2021/ 2022-01-26T16:22:51+00:00 https://www.tempus.com/news/pr/tempus-unveils-its-scalable-tumor-organoid-screening-platform-in-cell-reports-study/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-xf-liquid-biopsy-assay-demonstrates-extensive-analytical-and-clinical-validity-in-npj-precision-oncology-study/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-launches-hereditary-cancer-germline-assay-xg/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-announces-sequencing-and-computational-biology-collaboration-with-kronos-bio-to-support-the-development-of-cdk9-inhibitor-kb-0742/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-launches-hereditary-cancer-germline-assay-xg/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-introduces-a-new-predictive-diagnostic-test-to-its-growing-collection-of-algorithms/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-launches-new-precision-medicine-driven-tests-tempushrd-and-tempusto/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-ce-marks-its-broad-panel-genomic-sequencing-test-xt/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/kronos-bio-and-tempus-announce-multi-year-collaboration-to-provide-kronos-bio-with-access-to-tempus-platform/ 2022-01-26T16:23:07+00:00 https://www.tempus.com/news/pr/tempus-and-university-of-michigan-collaborate-on-breast-cancer-initiative/ 2022-01-26T16:23:08+00:00 https://www.tempus.com/news/pr/tempus-xo-assay-validation/ 2022-01-26T16:23:08+00:00 https://www.tempus.com/news/pr/tempus-unveils-tempus-xt-595-gene-panel-aimed-at-empowering-data-driven-cancer-care/ 2022-01-26T16:23:08+00:00 https://www.tempus.com/news/pr/tempus-to-participate-in-the-nci-match-clinical-trial/ 2022-01-26T16:23:08+00:00 https://www.tempus.com/news/an-operating-system-for-cancer/ 2022-01-26T16:25:32+00:00 https://www.tempus.com/publications/resolving-classification-of-pten-variants-using-gene-specific-acmg-amp-guidelines-a-first-review-of-curation-efforts-by-the-clingen-pten-variant-curation-expert-panel/ 2022-02-02T00:17:23+00:00 https://www.tempus.com/news/pr/tempus-incorporates-oncokb-data-and-nccn-guidelines-into-its-clinical-reports/ 2022-04-27T05:09:34+00:00 https://www.tempus.com/news/pr/characterization-of-kras-mutation-variants-and-prevalence-of-kras-g12c-in-gastrointestinal-malignancies/ 2022-04-27T05:12:11+00:00 https://www.tempus.com/publications/predicting-chemosensitivity-in-epithelial-ovarian-cancer-using-patient-derived-tissue-organoids/ 2022-04-27T05:12:14+00:00 https://www.tempus.com/publications/prediction-of-mortality-from-12-lead-electrocardiogram-voltage-data-using-a-deep-neural-network/ 2022-04-27T05:12:14+00:00 https://www.tempus.com/publications/overall-survival-os-in-advanced-non-small-cell-lung-cancer-ansclc-patients-treated-with-frontline-chemotherapy-or-immunotherapy-by-comorbidity-a-real-world-data-rwd-collaboration/ 2022-04-27T05:12:14+00:00 https://www.tempus.com/publications/rna-pathway-enrichment-in-serum-based-mass-spectroscopy-prognostic-analyses/ 2022-04-27T05:12:14+00:00 https://www.tempus.com/news/pr/tempus-announces-sequencing-collaboration-with-lilly-to-expand-access-to-genomic-testing/ 2022-07-14T21:12:23+00:00 https://www.tempus.com/news/pr/tempus-ce-marks-its-broad-panel-genomic-sequencing-and-algorithmic-diagnostic-tests/ 2022-07-14T21:12:31+00:00 https://www.tempus.com/news/pr/tempus-announces-14-abstracts-accepted-for-presentation-at-the-american-society-of-clinical-oncology-annual-meeting-2022/ 2022-07-14T21:12:35+00:00 https://www.tempus.com/news/pr/tempus-to-launch-largest-clinically-available-liquid-biopsy-panel-xf/ 2022-07-14T21:12:39+00:00 https://www.tempus.com/news/pr/tempus-and-geisinger-find-ecg-based-ai-model-can-predict-undiagnosed-structural-heart-disease/ 2022-07-14T21:12:42+00:00 https://www.tempus.com/news/pr/tempus-launches-psychiatric-real-world-data-program-to-advance-personalized-medicine/ 2022-07-14T21:12:46+00:00 https://www.tempus.com/news/pr/tempus-announces-agreement-with-the-united-states-department-of-veterans-affairs-national-precision-oncology-program-to-expand-access-to-genomic-testing-for-veterans-with-cancer/ 2022-07-14T21:12:49+00:00 https://www.tempus.com/news/pr/tempus-announces-abstracts-accepted-for-presentation-at-the-american-association-for-cancer-research-annual-meeting-2022/ 2022-07-14T21:12:53+00:00 https://www.tempus.com/news/pr/tempus-edge-platform-leverages-data-ai-to-identify-therapeutic-options-for-patients-earlier-in-the-treatment-journey/ 2022-07-14T21:12:58+00:00 https://www.tempus.com/news/pr/tempus-announces-the-acquisition-of-highline-sciences/ 2022-07-14T21:13:03+00:00 https://www.tempus.com/news/pr/tempus-announces-open-enrollment-for-study-in-collaboration-with-gsk-to-evaluate-niraparib-in-advanced-solid-tumor-patients-with-palb2-mutations/ 2022-07-14T21:13:08+00:00 https://www.tempus.com/news/pr/tempus-announces-six-abstracts-accepted-for-poster-presentation-at-the-2021-san-antonio-breast-cancer-symposium/ 2022-07-14T21:13:11+00:00 https://www.tempus.com/news/pr/tempus-announces-agreement-with-janssen-rd-to-leverage-ai-ml-and-real-world-evidence-to-enhance-the-discovery-and-development-of-oncology-therapies/ 2022-07-14T21:13:14+00:00 https://www.tempus.com/news/pr/tempus-announces-research-collaboration-with-intermountain-healthcare-to-advance-precision-oncology-research/ 2022-07-14T21:13:30+00:00 https://www.tempus.com/news/partnerships/ayala-pharmaceuticals/ 2022-07-19T13:40:11+00:00 https://www.tempus.com/wp-content/uploads/2021/04/Ayalabluetransparent-e1617658035716.png https://www.tempus.com/news/media-coverage/fast-company-op-ed-we-need-health-data-banks-not-unlike-what-we-have-for-organ-donors/ 2022-08-07T22:42:48+00:00 https://www.tempus.com/news/media-coverage/fortune-brainstorm-health-conference-2020-patients-first-transforming-care-through-disruptive-technology/ 2022-08-08T14:09:14+00:00 https://www.tempus.com/news/media-coverage/fierce-healthcare/ 2022-08-08T14:09:23+00:00 https://www.tempus.com/news/media-coverage/inside-indiana-business/ 2022-08-08T14:09:53+00:00 https://www.tempus.com/news/media-coverage/cnbc/ 2022-08-08T14:10:05+00:00 https://www.tempus.com/news/media-coverage/clinical-omics/ 2022-08-08T14:10:14+00:00 https://www.tempus.com/news/media-coverage/bioworld/ 2022-08-08T14:10:22+00:00 https://www.tempus.com/news/media-coverage/stat-news/ 2022-08-08T14:10:32+00:00 https://www.tempus.com/news/media-coverage/genomeweb/ 2022-08-08T14:10:41+00:00 https://www.tempus.com/news/media-coverage/cnbc-3/ 2022-08-08T14:10:49+00:00 https://www.tempus.com/news/media-coverage/fortune/ 2022-08-08T14:10:58+00:00 https://www.tempus.com/news/media-coverage/cnbc-2/ 2022-08-08T14:11:06+00:00 https://www.tempus.com/news/media-coverage/cleveland-clinic/ 2022-08-08T14:11:14+00:00 https://www.tempus.com/news/media-coverage/forbes/ 2022-08-08T14:11:22+00:00 https://www.tempus.com/news/media-coverage/milken-institute/ 2022-08-08T14:11:34+00:00 https://www.tempus.com/news/media-coverage/genomeweb-2/ 2022-08-08T14:12:23+00:00 https://www.tempus.com/news/media-coverage/the-atlantic/ 2022-08-08T14:12:32+00:00 https://www.tempus.com/news/media-coverage/forbes-2/ 2022-08-08T14:12:40+00:00 https://www.tempus.com/news/media-coverage/medcitynews/ 2022-08-08T14:12:47+00:00 https://www.tempus.com/news/media-coverage/biocentury-2/ 2022-08-08T14:12:56+00:00 https://www.tempus.com/news/media-coverage/chicago-inno/ 2022-08-08T14:13:06+00:00 https://www.tempus.com/publications/comparison-of-the-tumor-immune-microenvironment-and-checkpoint-blockade-biomarkers-between-stage-iii-and-iv-non-small-cell-lung-cancer/ 2022-08-29T19:26:10+00:00 https://www.tempus.com/publications/integration-of-tumor-extrinsic-and-intrinsic-features-associates-with-immunotherapy-response-in-non-small-cell-lung-cancer/ 2022-08-29T19:26:31+00:00 https://www.tempus.com/publications/comprehensive-genomic-profiling-in-advanced-metastatic-colorectal-cancer-number-needed-to-test-and-budget-impact-of-expanded-first-line-use-2/ 2022-08-29T20:43:43+00:00 https://www.tempus.com/publications/pilot-study-parp1-imaging-in-advanced-prostate-cancer/ 2022-08-29T20:44:12+00:00 https://www.tempus.com/publications/clinical-genomic-and-transcriptomic-data-profiling-of-biliary-tract-cancer-reveals-subtype-specific-immune-signatures/ 2022-08-29T20:44:31+00:00 https://www.tempus.com/publications/longitudinal-shifts-of-solid-tumor-and-liquid-biopsy-sequencing-concordance-in-metastatic-breast-cancer/ 2022-08-29T20:44:47+00:00 https://www.tempus.com/publications/validation-of-genomic-and-transcriptomic-models-of-homologous-recombination-deficiency-in-a-real-world-pan-cancer-cohort-2/ 2022-08-29T20:45:02+00:00 https://www.tempus.com/publications/circulating-tumor-dna-ctdna-mutations-associate-with-response-in-patients-pts-with-extensive-stage-small-cell-lung-cancer-es-sclc-treated-with-talazoparib-tala-and-temozolomide-tmz/ 2022-08-29T20:47:13+00:00 https://www.tempus.com/publications/microsatellite-stable-tumors-with-high-tumor-mutational-burden-in-association-with-tumor-response-to-immune-checkpoint-inhibitor-therapy-across-solid-tumors-and-correlation-with-specific-oncogenic-alt/ 2022-08-29T20:47:42+00:00 https://www.tempus.com/publications/genetic-alterations-in-tumor-tissue-and-cell-free-dna-in-patients-with-papillary-thyroid-carcinoma-at-initial-surgery/ 2022-08-29T20:49:15+00:00 https://www.tempus.com/publications/long-term-survival-in-newly-diagnosed-ovarian-cancer-patients/ 2022-08-29T20:49:58+00:00 https://www.tempus.com/publications/investigating-the-impact-of-ngs-data-availability-on-clinical-decision-making-in-brain-cancer/ 2022-08-29T20:52:05+00:00 https://www.tempus.com/publications/crestone-initial-efficacy-and-safety-of-seribantumab-in-solid-tumors-harboring-nrg1-fusions/ 2022-08-29T20:53:54+00:00 https://www.tempus.com/publications/targeting-b7-h3-in-prostate-cancer-phase-2-trial-in-localized-prostate-cancer-using-the-anti-b7-h3-antibody-enoblituzumab-with-biomarker-correlatives/ 2022-08-29T20:54:41+00:00 https://www.tempus.com/publications/multi-institutional-study-of-the-frequency-genomic-landscape-and-outcome-of-idh-mutant-glioma-in-pediatrics/ 2022-08-29T21:09:18+00:00 https://www.tempus.com/publications/prevalence-of-germline-findings-among-tumors-from-cancer-types-lacking-hereditary-testing-guidelines/ 2022-08-29T21:09:36+00:00 https://www.tempus.com/publications/protocol-for-drug-screening-of-patient-derived-tumor-organoids-using-high-content-fluorescent-imaging/ 2022-08-29T21:09:54+00:00 https://www.tempus.com/publications/precision-health-diagnostic-and-surveillance-network-uses-s-gene-target-failure-sgtf-combined-with-sequencing-technologies-to-track-emerging-sars-cov-2-variants/ 2022-08-29T21:10:17+00:00 https://www.tempus.com/publications/refining-colorectal-cancer-classification-and-clinical-stratification-through-a-single-cell-atlas/ 2022-08-29T21:10:35+00:00 https://www.tempus.com/publications/rechommend-an-ecg-based-machine-learning-approach-for-identifying-patients-at-high-risk-of-undiagnosed-structural-heart-disease-detectable-by-echocardiography/ 2022-08-29T21:10:53+00:00 https://www.tempus.com/publications/landscape-of-krasg12c-associated-genomic-alterations-and-interrelation-with-immuno-oncology-biomarkers-in-kras-mutated-cancers/ 2022-08-29T21:14:14+00:00 https://www.tempus.com/publications/deep-learning-identifies-microsatellite-instability-in-he-whole-slide-images-from-prostate-esophageal-and-gastric-cancers-and-generalizes-across-cancer-types/ 2022-08-29T21:16:44+00:00 https://www.tempus.com/publications/imaging-based-histological-features-are-predictive-of-met-alterations-in-non-small-cell-lung-cancer/ 2022-08-29T21:22:37+00:00 https://www.tempus.com/publications/genomic-and-transcriptomic-comparison-between-breast-cancers-from-patients-of-african-and-european-genetically-determined-ancestries-demonstrates-potential-for-ancestry-specific-biomarker-informed-the/ 2022-08-29T21:22:58+00:00 https://www.tempus.com/publications/temporal-concordance-rates-of-pathogenic-variants-in-liquid-biopsies-taken-after-solid-tissue-ngs-profiling-in-a-real-world-pan-cancer-cohortcopy/ 2022-08-29T21:23:48+00:00 https://www.tempus.com/publications/real-world-clinical-genomic-analysis-of-patients-with-braf-mutated-cancers-identifies-braf-class-ii-and-iii-as-a-population-of-unmet-medical-need/ 2022-08-29T21:24:52+00:00 https://www.tempus.com/publications/crizotinib-in-patients-with-tumors-harboring-alk-or-ros1-rearrangements-in-the-nci-match-trial/ 2022-08-29T21:25:13+00:00 https://www.tempus.com/news/tempus-announces-three-abstracts-accepted-for-presentation-at-the-european-society-for-medical-oncology-congress-2022/ 2022-09-09T13:38:13+00:00 https://www.tempus.com/publications/safety-tolerability-and-efficacy-of-agonist-anti-cd27-antibody-varlilumab-administered-in-combination-with-anti-pd-1-nivolumab-in-advanced-solid-tumors/ 2022-09-09T21:54:08+00:00 https://www.tempus.com/publications/discoidin-domain-receptor-driven-gene-signatures-as-markers-of-patient-response-to-anti-pd-l1-immune-checkpoint-therapy/ 2022-09-14T22:16:30+00:00 https://www.tempus.com/news/tempus-announces-collaboration-with-the-childrens-oncology-group-to-expand-access-to-genomic-testing-for-pediatric-cancer-patients/ 2022-09-20T13:22:38+00:00 https://www.tempus.com/publications/pharmacogenomic-testing-and-depressive-symptom-remission-a-systematic-review-and-meta-analysis-of-prospective-controlled-clinical-trials-2/ 2022-09-21T21:28:30+00:00 https://www.tempus.com/publications/response-to-selpercatinib-in-a-patient-with-recurrent-glioblastoma-and-ret-amplification/ 2022-09-21T21:33:12+00:00 https://www.tempus.com/publications/real-world-experience-of-ntrk-fusion-positive-thyroid-cancer/ 2022-09-21T21:43:56+00:00 https://www.tempus.com/publications/interrelation-of-functional-homologous-recombination-deficiency-and-hrr-pathway-alterations-in-prostate-cancer/ 2022-09-21T21:44:24+00:00 https://www.tempus.com/publications/actionable-genomic-landscapes-from-a-real-world-cohort-of-localized-urothelial-carcinoma-patients/ 2022-09-21T21:46:39+00:00 https://www.tempus.com/publications/association-of-renal-cell-carcinoma-rcc-metastatis-to-pancreas-with-a-distinct-molecular-profile-and-immune-cell-population/ 2022-09-21T21:46:59+00:00 https://www.tempus.com/publications/homologous-recombination-deficiency-concepts-definitions-and-assays/ 2022-09-21T21:47:21+00:00 https://www.tempus.com/publications/prevalence-of-germline-mutations-and-homologous-recombination-deficiency-hrd-in-a-real-world-biliary-tract-cancer-btc-cohort/ 2022-09-21T21:47:42+00:00 https://www.tempus.com/publications/next-generation-sequencing-ngs-to-identify-relapsed-gastrointestinal-gi-solid-tumor-patients-with-human-leukocyte-antigen-hla-loss-of-heterozygosity-loh-for-future-logic-gated-car-t-therapy-to/ 2022-09-21T21:48:13+00:00 https://www.tempus.com/publications/genomic-landscape-of-erbb2-3-alterations-in-colorectal-cancer-comutations-immuno-oncology-biomarkers-and-consensus-molecular-subtype/ 2022-09-21T21:48:36+00:00 https://www.tempus.com/publications/homologous-recombination-repair-pathway-alterations-and-their-relationship-to-homologous-recombination-deficiency-in-advanced-pancreatic-cancer-patients/ 2022-09-21T21:48:58+00:00 https://www.tempus.com/publications/viral-dynamics-and-duration-of-pcr-positivity-of-the-sars-cov-2-omicron-variant/ 2022-09-21T21:49:20+00:00 https://www.tempus.com/publications/neoadjuvant-chemotherapy-induces-genomic-and-transcriptomic-changes-in-ovarian-cancer/ 2022-09-21T21:49:39+00:00 https://www.tempus.com/publications/validation-of-genomic-and-transcriptomic-models-of-homologous-recombination-deficiency-in-a-real-world-pan-cancer-cohort/ 2022-09-21T21:51:02+00:00 https://www.tempus.com/publications/multi-omic-profiling-of-simultaneous-ductal-carcinoma-in-situ-and-invasive-breast-cancer/ 2022-09-21T21:53:26+00:00 https://www.tempus.com/publications/loss-of-asxl1-tumor-suppressor-promotes-resistance-to-cdk4-6-inhibitors-in-er-breast-cancer/ 2022-09-21T21:55:25+00:00 https://www.tempus.com/publications/the-frequency-and-somatic-mutation-landscape-of-fibroblast-growth-factor-receptor-fgfr-alterations-in-breast-cancer/ 2022-09-21T21:57:24+00:00 https://www.tempus.com/publications/genomic-landscape-of-her2-negative-advanced-or-metastatic-breast-cancer-with-pik3ca-gain-of-function-mutations/ 2022-09-21T21:59:45+00:00 https://www.tempus.com/publications/a-platform-of-cdk4-6-inhibitor-resistant-patient-derived-breast-cancer-organoids-illuminates-mechanisms-of-resistance-and-therapeutic-vulnerabilities/ 2022-09-23T16:11:18+00:00 https://www.tempus.com/publications/preclinical-activity-of-kb-0742-an-oral-highly-selective-cdk9-inhibitor-in-cell-lines-and-in-myc-high-expressing-patient-derived-models-of-multiple-breast-cancer-subtypes/ 2022-09-23T16:13:08+00:00 https://www.tempus.com/publications/comprehensive-molecular-characterization-of-patients-with-metastatic-invasive-lobular-carcinoma-ilc-using-real-world-data-to-describe-this-unique-clinical-entity/ 2022-09-23T16:15:19+00:00 https://www.tempus.com/publications/the-genomic-and-transcriptomic-landscape-of-pik3r1-mutated-breast-cancers/ 2022-09-23T16:26:53+00:00 https://www.tempus.com/publications/characterization-of-the-immune-landscape-of-primary-vs-metastatic-breast-cancer-in-a-real-world-data-cohort/ 2022-09-23T16:33:34+00:00 https://www.tempus.com/publications/viral-dynamics-of-sars-cov-2-variants-in-vaccinated-and-unvaccinated-persons/ 2022-09-23T16:35:25+00:00 https://www.tempus.com/publications/impact-of-next-generation-sequencing-on-interobserver-agreement-and-diagnosis-of-spitzoid-neoplasms/ 2022-09-23T22:15:22+00:00 https://www.tempus.com/publications/systematic-review-and-meta-analysis-of-l-methylfolate-augmentation-in-depressive-disorders/ 2022-09-23T22:16:49+00:00 https://www.tempus.com/publications/fibroblasts-as-paracrine-targets-of-the-oncometabolite-d-2-hg-in-the-idh1-mutant-cholangiocarcinoma-tumor-microenvironment/ 2022-09-23T22:19:04+00:00 https://www.tempus.com/publications/basecamp-1-an-observational-study-to-identify-relapsed-solid-tumor-patients-with-human-leukocyte-antigen-hla-loss-of-heterozygosity-loh-and-leukapheresis-for-future-car-t-cell-therapy/ 2022-09-23T22:21:27+00:00 https://www.tempus.com/publications/characterization-of-tumor-infiltrating-t-cell-repertoire-in-human-cancers/ 2022-09-23T22:23:07+00:00 https://www.tempus.com/publications/rapid-detection-of-somatic-variants-in-human-leukocyte-antigen-class-1-genes-from-solid-tumor-samples/ 2022-09-23T22:26:39+00:00 https://www.tempus.com/publications/9413-2/ 2022-09-23T22:28:05+00:00 https://www.tempus.com/publications/an-ecg-based-machine-learning-model-for-predicting-new-onset-atrial-fibrillation-is-superior-to-age-and-clinical-variables-in-selecting-a-population-at-high-stroke-risk/ 2022-09-23T22:30:53+00:00 https://www.tempus.com/publications/prediction-of-drug-induced-qtc-prolongation-with-an-ecg-based-machine-learning-model/ 2022-09-23T22:32:54+00:00 https://www.tempus.com/publications/assessing-the-role-of-bcor-bcorl1-and-other-historically-low-frequency-somatic-mutations-in-myelodysplastic-syndromes/ 2022-09-26T18:54:23+00:00 https://www.tempus.com/publications/mouse-intraductal-mind-an-in-vivo-model-for-studying-the-underlying-mechanisms-of-dcis-malignancy/ 2022-09-26T18:55:59+00:00 https://www.tempus.com/publications/clinical-outcomes-and-longitudinal-circulating-tumor-dna-changes-after-treatment-with-nivolumab-and-olaparib-in-immunotherapy-relapsed-melanoma-with-detected-homologous-recombination-deficiency/ 2022-09-26T18:58:27+00:00 https://www.tempus.com/publications/the-friends-of-cancer-research-real-world-data-collaboration-pilot-2-0-methodological-recommendations-from-oncology-case-studies/ 2022-09-26T18:59:20+00:00 https://www.tempus.com/publications/multi-platform-classification-of-idh-wild-type-glioblastoma-based-on-erk-mapk-pathway-diagnostic-prognostic-and-therapeutic-implications/ 2022-09-26T19:02:32+00:00 https://www.tempus.com/publications/ancestry-inference-from-targeted-ngs-tests-to-enable-precision-medicine-and-improve-racial-ethnic-representation-in-clinical-trials/ 2022-09-26T19:04:58+00:00 https://www.tempus.com/publications/the-friends-of-cancer-research-real-world-data-rwd-pilot-2-0-collaboration-implementation-of-standardized-methodological-approaches-for-evaluation-of-oncology-rwd/ 2022-09-26T19:11:40+00:00 https://www.tempus.com/publications/utilizing-patient-derived-epithelial-ovarian-cancer-tumor-organoids-to-predict-carboplatin-resistance/ 2022-09-26T19:13:11+00:00 https://www.tempus.com/publications/germline-atm-mutation-and-somatic-pik3ca-and-bcor-mutations-found-in-an-infant-with-aggressive-orbital-embryonal-rhabdomyosarcoma/ 2022-09-26T19:14:53+00:00 https://www.tempus.com/publications/a-pan-cancer-organoid-platform-for-precision-medicine/ 2022-09-26T19:16:18+00:00 https://www.tempus.com/publications/somatic-tumor-profile-analysis-in-a-patient-with-germline-pms2-mutation-and-synchronous-ovarian-and-uterine-carcinomas/ 2022-09-26T20:19:41+00:00 https://www.tempus.com/publications/validation-of-a-liquid-biopsy-assay-with-molecular-and-clinical-profiling-of-circulating-tumor-dna/ 2022-09-26T20:20:51+00:00 https://www.tempus.com/publications/deep-orthogonal-fusion-multimodal-prognostic-biomarker-discovery-integrating-radiology-pathology-genomic-and-clinical-data/ 2022-09-26T20:22:22+00:00 https://www.tempus.com/publications/summary-of-the-12-most-common-cancers-in-the-cancerlinq-discovery-clqd-database/ 2022-09-26T20:25:40+00:00 https://www.tempus.com/publications/characterizing-demographics-clinical-and-genomic-characteristics-for-u-s-patients-with-hr-her2-metastatic-breast-cancer-following-progression-on-a-cdk4-and-6-inhibitor/ 2022-09-26T20:26:56+00:00 https://www.tempus.com/publications/recommendations-for-reporting-of-secondary-findings-in-clinical-exome-and-genome-sequencing/ 2022-09-26T20:28:24+00:00 https://www.tempus.com/publications/comprehensive-genomic-profiling-in-advanced-metastatic-colorectal-cancer-number-needed-to-test-and-budget-impact-of-expanded-first-line-use/ 2022-09-26T20:30:20+00:00 https://www.tempus.com/publications/primary-pancreatic-adenocarcinoma-ppda-and-metastatic-pancreatic-adenocarcinoma-mpda-are-they-genomically-distinct/ 2022-09-26T20:32:08+00:00 https://www.tempus.com/publications/expanding-the-molecular-taxonomy-of-nut-midline-carcinomas-with-multiomic-analyses/ 2022-09-26T20:33:47+00:00 https://www.tempus.com/publications/leveraging-machine-learning-technology-to-efficiently-identify-and-match-patients-for-precision-oncology-clinical-trials/ 2022-09-26T20:35:35+00:00 https://www.tempus.com/publications/comprehensive-genomic-and-transcriptomic-profiling-of-pediatric-malignancies-using-the-tempus-xt-next-generation-sequencing-assay-to-identify-clinically-meaningful-alterations/ 2022-09-26T20:37:38+00:00 https://www.tempus.com/publications/multimodal-profiling-of-biliary-tract-cancers-to-detect-potentially-actionable-biomarkers-and-differences-in-immune-signatures-between-subtypes/ 2022-09-26T20:39:44+00:00 https://www.tempus.com/publications/a-review-of-evidence-supporting-nccn-category-2b-off-label-recommendations-for-determination-of-medicare-reimbursement-eligibility/ 2022-09-26T20:44:22+00:00 https://www.tempus.com/publications/rate-of-incidental-germline-findings-detected-by-tumor-normal-matched-sequencing-in-cancer-types-lacking-hereditary-cancer-testing-guidelines/ 2022-09-26T20:52:06+00:00 https://www.tempus.com/publications/the-time-trial-network-to-facilitate-rapid-clinical-trial-activation-patient-screening-and-enrollment-in-molecularly-targeted-trials/ 2022-09-26T20:53:42+00:00 https://www.tempus.com/publications/landscape-of-krasg12c-associated-genomic-alterations-and-interrelation-with-immuno-oncology-io-biomarkers/ 2022-09-26T20:56:05+00:00 https://www.tempus.com/publications/multiplex-qpcr-discriminates-variants-of-concern-to-enhance-global-surveillance-of-sars-cov-2/ 2022-09-26T21:02:49+00:00 https://www.tempus.com/publications/novel-targetable-fgfr2-and-fgfr3-alterations-in-glioblastoma-associate-with-aggressive-phenotype-and-distinct-gene-expression-programs/ 2022-09-26T21:04:40+00:00 https://www.tempus.com/publications/synthetic-lethality-mediated-precision-oncology-via-the-tumor-transcriptome/ 2022-09-26T21:06:42+00:00 https://www.tempus.com/publications/early-introductions-and-transmission-of-sars-cov-2-variant-b-1-1-7-in-the-united-states/ 2022-09-26T21:08:24+00:00 https://www.tempus.com/publications/transferring-diagnostic-and-prognostic-molecular-models-across-technological-platforms/ 2022-09-26T21:12:57+00:00 https://www.tempus.com/publications/incidence-of-molecular-alterations-in-kras-and-other-known-cancer-genes-in-patients-with-pancreatic-cancer-assessed-with-a-commercial-genomic-profiling-panel-compared-to-tcga-results/ 2022-09-26T21:17:23+00:00 https://www.tempus.com/publications/characterizing-differences-in-checkpoint-inhibitor-biomarkers-in-a-real-world-cohort-of-stage-iii-and-iv-non-small-cell-lung-cancer-patients/ 2022-09-26T21:18:58+00:00 https://www.tempus.com/publications/genomic-characterization-and-monitoring-molecular-response-to-treatment-in-african-american-aa-advanced-prostate-cancer-pc-patients-pts-via-next-generation-sequencing-ngs-real-world-experienc/ 2022-09-26T21:20:26+00:00 https://www.tempus.com/publications/evaluating-clinical-features-and-prognostic-factors-associated-with-response-to-immune-checkpoint-blockade-in-mnsclc-patients/ 2022-09-26T21:21:38+00:00 https://www.tempus.com/publications/comprehensive-validation-of-rna-sequencing-for-clinical-ngs-fusion-genes-and-rna-expression-reporting/ 2022-09-26T21:22:59+00:00 https://www.tempus.com/publications/cytotoxic-cd4-t-cells-contribute-to-anti-tumor-immune-responses-in-nsclc/ 2022-09-26T21:24:23+00:00 https://www.tempus.com/publications/leveraging-rna-sequencing-for-scalable-tumor-immune-repertoire-profiling/ 2022-09-26T21:25:48+00:00 https://www.tempus.com/publications/successful-use-of-immunotherapy-to-treat-advanced-cutaneous-squamous-cell-carcinoma-in-recessive-dystrophic-epidermolysis-bullosa/ 2022-09-26T21:26:58+00:00 https://www.tempus.com/publications/deep-neural-networks-can-predict-new-onset-atrial-fibrillation-from-the-12-lead-electrocardiogram-and-help-identify-those-at-risk-of-af-related-stroke/ 2022-09-26T21:29:29+00:00 https://www.tempus.com/publications/prevalence-of-microsatellite-instability-and-monitoring-response-to-immune-checkpoint-inhibition-utilizing-liquid-biopsy-among-african-american-men-with-advanced-prostate-cancer/ 2022-09-26T21:33:59+00:00 https://www.tempus.com/publications/genomic-characterization-and-molecular-taxonomy-of-sarcomatoid-variant-prostate-cancer/ 2022-09-26T21:37:12+00:00 https://www.tempus.com/publications/genomic-landscape-of-advanced-prostate-cancer-in-racial-minority-populations-real-world-experience-in-a-safety-net-hospital-oncology-clinic/ 2022-09-26T21:39:06+00:00 https://www.tempus.com/publications/tumor-neoantigen-burden-and-immune-environment-in-driver-alteration-positive-lung-adenocarcinoma/ 2022-09-26T21:41:08+00:00 https://www.tempus.com/publications/very-low-mutation-burden-is-a-feature-of-inflamed-recurrent-glioblastomas-responsive-to-cancer-immunotherapy/ 2022-09-26T21:42:24+00:00 https://www.tempus.com/publications/chemoradiation-induced-molecular-alterations-and-associated-outcomes-in-patients-with-rectal-cancer/ 2022-09-26T21:43:52+00:00 https://www.tempus.com/publications/real-world-evidence-of-diagnostic-testing-and-treatment-patterns-in-us-patients-with-breast-cancer-with-implications-for-treatment-biomarkers-from-rna-sequencing-data/ 2022-09-26T21:48:43+00:00 https://www.tempus.com/publications/patient-similarity-network-of-multiple-myeloma-identifies-patient-subgroups-with-distinct-genetic-and-clinical-features/ 2022-09-26T21:50:54+00:00 https://www.tempus.com/publications/genomic-landscape-analysis-of-ctdna-alterations-in-cholangiocarcinoma/ 2022-09-26T21:51:17+00:00 https://www.tempus.com/publications/whole-exome-sequencing-identifies-a-somatic-cell-mutation-signature-that-predicts-relapse-risk-and-survival-probability-in-multiple-myeloma/ 2022-09-26T21:53:18+00:00 https://www.tempus.com/publications/comprehensive-genomic-and-transcriptomic-profiling-of-molecular-subtypes-reveal-ancestral-differences-in-the-activity-of-signaling-pathways-between-patients-with-african-and-european-ancestry/ 2022-09-26T21:59:56+00:00 https://www.tempus.com/news/tempus-announces-companion-diagnostic-collaboration-with-kartos-therapeutics/ 2022-10-06T11:00:13+00:00 https://www.tempus.com/publications/artificial-intelligence-augmented-histopathologic-review-using-image-analysis-to-optimize-dna-yield-from-formalin-fixed-paraffin-embedded-slides/ 2022-10-05T16:41:56+00:00 https://www.tempus.com/publications/unstable-mutational-profile-and-heterogeneity-of-residual-breast-tumor-following-neoadjuvant-therapy-from-comprehensive-genomic-and-transcriptomic-sequencing/ 2022-10-07T20:08:38+00:00 https://www.tempus.com/publications/concordance-and-use-patterns-of-tissue-and-cell-free-based-genomic-testing-in-metastatic-breast-cancer/ 2022-10-07T20:10:27+00:00 https://www.tempus.com/publications/ongoing-partial-response-at-6-months-to-olaparib-for-metastatic-melanoma-with-somatic-palb2-mutation-after-failure-of-immunotherapy-a-case-report/ 2022-10-07T20:11:50+00:00 https://www.tempus.com/publications/next-generation-sequencing-ngs-in-older-adults-with-breast-cancer-using-tissue-based-and-circulating-tumor-dna-ctdna-assays/ 2022-10-07T21:08:46+00:00 https://www.tempus.com/publications/spatial-and-temporal-heterogeneity-of-pd-l1-expression-and-tumor-mutational-burden-in-gastroesophageal-adenocarcinoma-at-baseline-diagnosis-and-after-chemotherapy/ 2022-10-07T21:13:39+00:00 https://www.tempus.com/publications/prediction-of-incident-af-with-deep-learning-can-identify-patients-at-high-risk-for-af-related-stroke/ 2022-10-07T21:19:44+00:00 https://www.tempus.com/publications/safety-and-efficacy-of-a-randomized-phase-i-trial-to-evaluate-concurrent-or-sequential-ipilimumab-nivolumab-and-stereotactic-body-radiotherapy-in-patients-with-stage-iv-non-small-cell-lung-cancer-c/ 2022-10-07T21:23:31+00:00 https://www.tempus.com/publications/targeted-next-generation-sequencing-ngs-of-105-cancer-related-genes-in-circulating-tumor-dna-ctdna-from-patients-with-advanced-cancers-treated-with-immune-checkpoint-inhibitors-icpi/ 2022-10-07T21:26:58+00:00 https://www.tempus.com/publications/complete-response-in-a-patient-with-chemorefractory-egfr-amplified-pd-l1-positive-metastatic-gastric-cancer-treated-by-dual-anti-egfr-and-anti-pd-1-monoclonal-antibody-therapy/ 2022-10-07T21:31:53+00:00 https://www.tempus.com/publications/global-activation-of-oncogenic-pathways-underlies-therapy-resistance-in-diffuse-midline-glioma/ 2022-10-07T21:41:49+00:00 https://www.tempus.com/publications/molecular-analysis-of-atypical-deep-penetrating-nevus-progressing-to-melanoma/ 2022-10-07T21:44:59+00:00 https://www.tempus.com/publications/development-and-characterization-of-patient-derived-xenografts-from-non-small-cell-lung-cancer-brain-metastases/ 2022-10-07T21:46:29+00:00 https://www.tempus.com/publications/recurrent-transcriptionally-active-esr1-fusions-render-therapeutic-vulnerabilities-to-kinase-inhibition-in-advanced-breast-cancer/ 2022-10-07T21:52:33+00:00 https://www.tempus.com/publications/accurate-estimation-of-circulating-tumor-dna-fraction-from-ultra-low-pass-whole-genome-sequencing/ 2022-10-07T21:54:00+00:00 https://www.tempus.com/publications/universal-genetic-and-transcriptomic-concordance-metrics-to-validate-patient-derived-tumor-organoid-models/ 2022-10-07T22:02:42+00:00 https://www.tempus.com/publications/multimodal-prediction-of-diagnosis-for-cancers-of-unknown-primary-2/ 2022-10-07T22:04:31+00:00 https://www.tempus.com/publications/novel-genomic-variants-and-pathways-associated-with-baseline-serum-thymidine-kinase-1-levels-in-hr-positive-her2-negative-mbc-patients-commencing-palbociclib-and-letrozole/ 2022-10-10T18:42:40+00:00 https://www.tempus.com/publications/identification-of-novel-druggable-fusions-enabled-through-the-use-of-an-automated-rna-fusion-prioritization-pipeline/ 2022-10-14T21:22:39+00:00 https://www.tempus.com/publications/large-scale-ultradeep-phenotypic-analysis-of-patient-derived-tumor-organoids-unveils-intra-and-inter-tumor-heterogeneity-of-drug-response/ 2022-10-14T21:24:50+00:00 https://www.tempus.com/publications/robust-detection-of-sequencing-batch-effects-in-rna-through-low-dimensional-embedding-with-subtype-matched-reference-samples/ 2022-10-14T21:26:17+00:00 https://www.tempus.com/publications/transcriptome-background-tissue-correction-in-metastatic-cancers-using-a-correlated-composition-admixture-model/ 2022-10-14T21:27:46+00:00 https://www.tempus.com/publications/learning-relevant-he-slide-morphologies-for-prediction-of-colorectal-cancer-tumor-mutational-burden-using-weakly-supervised-deep-learning/ 2022-10-14T21:30:27+00:00 https://www.tempus.com/publications/greater-than-two-coexisting-mutations-in-kras-and-nras-identified-in-the-circulating-tumor-dna-fraction-of-liquid-biopsies-by-ngs-and-confirmed-with-ddpcr/ 2022-10-14T21:31:56+00:00 https://www.tempus.com/publications/towards-cancer-mega-cohorts-a-novel-homogenization-algorithm-applied-to-diverse-breast-cancer-rna-seq-datasets/ 2022-10-14T21:33:28+00:00 https://www.tempus.com/publications/an-integrative-molecular-framework-to-predict-homologous-recombination-deficiency/ 2022-10-14T21:38:02+00:00 https://www.tempus.com/publications/he-image-based-consensus-molecular-subtype-classification-of-colorectal-cancer-using-weak-labeling/ 2022-10-14T21:40:24+00:00 https://www.tempus.com/publications/trends-in-immunotherapy-use-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc-patients-analysis-of-real-world-data/ 2022-10-14T21:47:09+00:00 https://www.tempus.com/publications/evaluating-the-clinical-environmental-genetic-and-genomic-profile-of-men-with-early-onset-aggressive-prostate-cancer-pca/ 2022-10-14T21:48:56+00:00 https://www.tempus.com/publications/real-world-conditional-survival-analysis-of-women-with-newly-diagnosed-ovarian-cancer/ 2022-10-14T21:50:35+00:00 https://www.tempus.com/news/gsk-announces-expanded-collaboration-with-tempus-in-precision-medicine-to-accelerate-rd/ 2022-10-18T13:21:20+00:00 https://www.tempus.com/news/tempus-announces-275-million-in-funding/ 2022-10-20T13:00:07+00:00 https://www.tempus.com/news/tempus-announces-dr-kate-sasser-as-chief-scientific-officer/ 2022-10-25T13:00:43+00:00 https://www.tempus.com/news/tempus-announces-real-world-data-driven-program-to-accelerate-precision-oncology-research/ 2022-10-28T14:28:12+00:00 https://www.tempus.com/news/tempus-launches-first-cardiology-prospective-study-for-its-ai-enabled-predictive-tests/ 2022-11-03T13:15:09+00:00 https://www.tempus.com/news/tempus-announces-six-abstracts-accepted-for-presentation-at-the-american-heart-association-scientific-sessions-2022/ 2022-11-04T12:30:59+00:00 https://www.tempus.com/publications/challenges-and-opportunities-associated-with-the-md-anderson-impact2-randomized-study-in-precision-oncology/ 2022-11-04T15:36:04+00:00 https://www.tempus.com/news/tempus-announces-six-abstracts-accepted-for-presentation-at-the-2022-society-for-immunotherapy-of-cancer-annual-meeting/ 2022-11-09T13:00:17+00:00 https://www.tempus.com/publications/clinical-validation-of-the-tempus-xo-assay/ 2022-11-10T00:47:06+00:00 https://www.tempus.com/publications/recurrent-glioblastoma-treated-with-recombinant-poliovirus/ 2022-11-10T00:52:14+00:00 https://www.tempus.com/publications/genomic-fusions-in-pigmented-spindle-cell-nevus-of-reed/ 2022-11-10T00:55:17+00:00 https://www.tempus.com/publications/gene%e2%80%90specific-criteria-for-pten-variant-curation-recommendations-from-the-clingen-pten-expert-panel/ 2022-11-10T00:57:32+00:00 https://www.tempus.com/publications/spinal-pleomorphic-xanthoastrocytoma-with-a-qki-raf1-fusion/ 2022-11-10T01:00:02+00:00 https://www.tempus.com/publications/integrating-rna-expression-and-visual-features-for-immune-infiltrate-prediction/ 2022-11-10T01:04:12+00:00 https://www.tempus.com/publications/neural-network-based-framework-to-integrating-rna-seq-imaging-features-to-predict-tumor-immune-infiltration-score/ 2022-11-10T01:06:19+00:00 https://www.tempus.com/publications/a-multi-institutional-study-assessing-prevalence-of-deleterious-germline-mutations-in-pancreatic-cancer/ 2022-11-10T01:10:58+00:00 https://www.tempus.com/publications/tumor-mutational-burden-and-other-predictive-immunotherapy-markers-in-histiocytic-neoplasms/ 2022-11-10T01:14:06+00:00 https://www.tempus.com/publications/survey-of-the-immunogenomic-landscape-of-solid-tumors-through-clinical-dna-and-rna-sequencing/ 2022-11-10T01:16:15+00:00 https://www.tempus.com/publications/rna-sequencing-in-precision-cancer-immunotherapy/ 2022-11-10T01:19:04+00:00 https://www.tempus.com/publications/clinical-validation-of-the-tempus-xt-next-generation-targeted-oncology-sequencing-assay/ 2022-11-10T01:20:20+00:00 https://www.tempus.com/publications/genome-wide-analysis-of-glioblastoma-patients-with-unexpectedly-long-survival/ 2022-11-10T01:21:41+00:00 https://www.tempus.com/publications/predicting-oncogenic-viral-status-using-rna-signatures/ 2022-11-10T01:24:24+00:00 https://www.tempus.com/publications/activating-structural-alterations-in-mapk-genes-are-distinct-genetic-drivers-in-a-unique-subgroup-of-spitzoid-neoplasms/ 2022-11-10T01:25:56+00:00 https://www.tempus.com/publications/distinct-genomic-patterns-in-pigmented-epithelioid-melanocytoma-a-molecular-and-histologic-analysis-of-16-cases/ 2022-11-10T01:27:25+00:00 https://www.tempus.com/publications/design-and-development-of-the-molecular-analysis-for-therapy-choice-nci-match-designated-laboratory-network/ 2022-11-10T01:30:45+00:00 https://www.tempus.com/publications/a-phase-ii-single-arm-study-of-nivolumab-and-ipilimumab-nivo-ipi-in-previously-treated-classic-kaposi-sarcoma-cks/ 2022-11-10T01:34:01+00:00 https://www.tempus.com/publications/genomic-profiling-of-residual-tumor-after-neoadjuvant-chemotherapy-for-breast-cancer/ 2022-11-10T01:39:30+00:00 https://www.tempus.com/publications/determining-clinical-relevance-of-genomic-heterogeneity-in-an-ethnically-diverse-cohort-of-newly-diagnosed-patients-with-breast-cancer/ 2022-11-10T01:40:57+00:00 https://www.tempus.com/publications/overestimation-of-tumor-mutational-burden-tmb-using-algorithms-compared-to-germline-subtraction/ 2022-11-10T01:43:29+00:00 https://www.tempus.com/publications/real-world-prevalence-of-autoimmune-disease-ad-among-patients-pts-receiving-immune-checkpoint-inhibitors-ici-in-ascos-cancerlinq-database/ 2022-11-10T01:45:30+00:00 https://www.tempus.com/publications/characteristics-of-patients-receiving-immune-checkpoint-inhibitors-ici-in-ascos-cancerlinq/ 2022-11-10T01:47:11+00:00 https://www.tempus.com/publications/analysis-of-advanced-quantitative-computed-tomography-imaging-features-in-predicting-progression-free-survival-of-advanced-epithelial-ovarian-cancer/ 2022-11-18T22:53:58+00:00 https://www.tempus.com/publications/tumor-mutational-burden-from-tumor-only-sequencing-compared-with-germline-subtraction-from-paired-tumor-and-normal-specimens/ 2022-11-18T22:56:23+00:00 https://www.tempus.com/publications/genetic-and-histologic-spatiotemporal-evolution-of-recurrent-multifocal-multicentric-and-metastatic-glioblastoma/ 2022-11-18T22:57:46+00:00 https://www.tempus.com/publications/comparative-analysis-of-genomic-landscape-reveals-heterogeneity-in-her2-positive-primary-breast-cancers-and-residual-disease-following-neoadjuvant-therapy/ 2022-11-18T22:59:02+00:00 https://www.tempus.com/publications/integrating-next-generation-sequencing-with-morphology-improves-prognostic-and-biologic-classification-of-spitz-neoplasms/ 2022-11-18T23:00:11+00:00 https://www.tempus.com/publications/mutation-status-and-epithelial-differentiation-stratify-recurrence-risk-in-chordoid-meningioma-a-multicenter-study-with-high-prognostic-relevance/ 2022-11-18T23:01:22+00:00 https://www.tempus.com/publications/molecular-portraits-of-metastatic-breast-cancer-using-tissue-next-generation-sequencing/ 2022-11-18T23:02:45+00:00 https://www.tempus.com/publications/microsatellite-instability-detection-with-cell-free-dna-next-generation-sequencing/ 2022-11-18T23:04:22+00:00 https://www.tempus.com/publications/detection-of-human-leukocyte-antigen-class-i-loss-of-heterozygosity-in-solid-tumor-types-by-next-generation-dna-sequencing/ 2022-11-18T23:05:42+00:00 https://www.tempus.com/publications/presence-of-chip-mutated-autologous-hematopoietic-cells-in-mobilized-peripheral-blood-products-is-associated-with-shorter-progression-free-survival-after-autologous-transplants-for-multiple-myeloma/ 2022-11-18T23:07:08+00:00 https://www.tempus.com/publications/molecular-alterations-in-adult-histiocytic-neoplasms/ 2022-11-18T23:09:23+00:00 https://www.tempus.com/publications/a-feasibility-study-of-biologically-focused-therapy-for-myelodysplastic-syndrome-patients-refractory-to-hypomethylating-agents/ 2022-11-18T23:10:46+00:00 https://www.tempus.com/publications/identification-of-a-novel-role-for-pd-1-signaling-in-promotion-tumor-proliferation-in-b-cell-lymphoma/ 2022-11-18T23:12:14+00:00 https://www.tempus.com/publications/integrated-genomic-profiling-expands-clinical-options-for-patients-with-cancer/ 2022-11-18T23:13:14+00:00 https://www.tempus.com/publications/matched-whole-genome-sequencing-wgs-and-whole-exome-sequencing-wes-of-tumor-tissue-with-circulating-tumor-dna-ctdna-analysis-complementary-modalities-in-clinical-practice/ 2022-11-18T23:14:12+00:00 https://www.tempus.com/publications/smarc-b1-deficient-sinonasal-carcinoma-metastasis-to-the-brain-with-next-generation-sequencing-data-a-case-report-of-perineural-invasion-progressing-to-leptomeningeal-invasion/ 2022-11-18T23:15:10+00:00 https://www.tempus.com/publications/multi-field-of-view-deep-learning-model-predicts-non-small-cell-lung-cancer-programmed-death-ligand-1-status-from-whole-slide-hematoxylin-and-eosin-images/ 2022-11-18T23:16:18+00:00 https://www.tempus.com/publications/distinct-genomic-features-in-a-retrospective-cohort-of-mucosal-acral-and-vulvovaginal-melanomas/ 2022-11-18T23:18:54+00:00 https://www.tempus.com/publications/mutations-of-the-mapk-tsc-mtor-pathway-characterize-periventricular-glioblastoma-with-epithelioid-sega-like-morphology-morphological-and-therapeutic-implications-2/ 2022-11-18T23:19:53+00:00 https://www.tempus.com/publications/mutations-of-the-mapk-tsc-mtor-pathway-characterize-periventricular-glioblastoma-with-epithelioid-sega-like-morphology-morphological-and-therapeutic-implications/ 2022-11-18T23:20:52+00:00 https://www.tempus.com/publications/validation-of-a-transcriptome-based-assay-for-classifying-cancers-of-unknown-primary-origin/ 2022-11-21T23:26:16+00:00 https://www.tempus.com/publications/an-ntrk-1-associated-soft-tissue-tumor-showing-distinctive-nodules-with-peripheral-accentuation-of-cellularity/ 2022-11-21T23:28:08+00:00 https://www.tempus.com/publications/a-deep-learning-based-rna-seq-germline-variant-caller/ 2022-11-21T23:32:13+00:00 https://www.tempus.com/publications/racial-disparities-in-tumor-profiling-testing-inferred-from-continental-genetic-ancestry-determination-of-100000-cancer-patients/ 2022-11-22T22:48:55+00:00 https://www.tempus.com/publications/applying-machine-vision-to-empower-preclinical-development-of-immunotherapies-in-patient-derived-organoid-models-of-solid-tumors/ 2022-11-22T22:50:51+00:00 https://www.tempus.com/publications/tumor-mutational-burden-corrected-for-human-leukocyte-antigen-somatic-defects-predicts-response-to-checkpoint-blockade-in-advanced-non-small-cell-lung-cancer/ 2022-11-22T22:51:02+00:00 https://www.tempus.com/publications/racial-differences-in-tmb-measures-between-paired-tumor-normal-and-tumor-only-sequencing-across-endometrial-bladder-and-non-small-cell-lung-cancers/ 2022-11-22T22:51:14+00:00 https://www.tempus.com/publications/outcomes-following-first-line-immunotherapy-with-or-without-chemotherapy-stratified-by-kras-mutational-status-a-real-world-analysis-in-patients-with-advanced-nsclc/ 2022-11-22T22:51:23+00:00 https://www.tempus.com/publications/composite-deep-learning-ecg-algorithm-trained-to-identify-structural-heart-diseases-can-identify-clinically-ascertained-hypertrophic-cardiomyopathy/ 2022-11-22T22:57:02+00:00 https://www.tempus.com/publications/the-impact-of-time-censoring-on-machine-learning-models-which-identify-patients-with-undiagnosed-cardiac-amyloidosis/ 2022-11-22T22:57:30+00:00 https://www.tempus.com/publications/natural-language-processing-models-can-be-trained-to-accurately-recognize-the-presence-of-disease-within-clinical-notes/ 2022-11-22T22:57:39+00:00 https://www.tempus.com/publications/deep-learning-prediction-of-new-onset-atrial-fibrillation-using-echocardiography-videos/ 2022-11-22T22:57:48+00:00 https://www.tempus.com/publications/ehr-based-machine-learning-model-predicts-drug-induced-qt-prolongation-with-superior-performance-compared-to-clinical-risk-predictors/ 2022-11-22T22:57:57+00:00 https://www.tempus.com/publications/an-ehr-based-machine-learning-model-predicts-myocardial-infarction-better-than-an-ecg-based-machine-learning-model-and-the-pooled-cohort-equations/ 2022-11-22T22:58:07+00:00 https://www.tempus.com/publications/associations-of-genetic-ancestry-to-the-somatic-mutational-landscape-from-tumor-profiling-data-of-100000-cancer-patients/ 2022-11-22T22:58:44+00:00 https://www.tempus.com/publications/transfer-learning-of-a-methylation-based-covid-19-severity-model-for-dna-viral-infection-by-eczema-herpeticum/ 2022-11-22T22:58:53+00:00 https://www.tempus.com/publications/expanded-studies-of-a-methylation-based-covid-19-classification-model-to-predict-severity-of-disease-and-its-ability-to-differentiate-from-other-respiratory-viruses/ 2022-11-22T22:59:00+00:00 https://www.tempus.com/publications/a-methylation-based-covid-19-classification-model-to-predict-severe-disease-in-vaccinated-individuals/ 2022-11-22T22:59:09+00:00 https://www.tempus.com/publications/genetic-ancestry-differences-in-tumor-mutation-between-early-and-average-onset-colorectal-cancer/ 2022-11-22T22:59:19+00:00 https://www.tempus.com/publications/anti-tumor-activity-of-bdtx-1535-an-irreversible-cns-penetrant-inhibitor-of-multiple-egfr-extracellular-domain-alterations-in-preclinical-glioblastoma-models/ 2022-11-22T22:59:29+00:00 https://www.tempus.com/publications/peroxisome-proliferator-activated-receptor-gamma-pparg-status-defines-the-luminal-lineage-in-molecular-profiles-of-advanced-urothelial-cancer-uc-tumors/ 2022-11-22T22:59:39+00:00 https://www.tempus.com/publications/pharmacogenomic-testing-and-depressive-symptom-remission-a-systematic-review-and-meta-analysis-of-prospective-controlled-clinical-trials/ 2022-11-22T23:01:10+00:00 https://www.tempus.com/publications/molecular-classification-of-cancers-of-unknown-primary-expands-and-refines-treatment-options/ 2022-11-22T23:01:26+00:00 https://www.tempus.com/publications/braf-mutations-and-fusions-in-a-real-world-cohort-of-nsclc-patients/ 2022-11-22T23:01:35+00:00 https://www.tempus.com/publications/the-genomic-landscape-of-small-cell-lung-cancer-in-never-smoking-patients/ 2022-11-22T23:01:42+00:00 https://www.tempus.com/publications/impact-of-braf-v600e-mutation-on-immunologic-characteristics-of-the-tumor-microenvironment-tme-and-associated-genomic-alterations-in-patients-with-microsatellite-instability-high-msi-h-or-mismatch-2/ 2022-11-22T23:01:50+00:00 https://www.tempus.com/publications/real-world-evidence-on-predictors-of-survival-for-hormone-positive-and-triple-negative-advanced-breast-cancer-by-treatment-and-brca-status-in-the-united-states/ 2022-11-22T23:01:59+00:00 https://www.tempus.com/publications/comparative-analysis-of-the-targetable-landscape-in-kras-mutated-and-wild-type-pancreatic-adenocarcinoma/ 2022-11-22T23:02:08+00:00 https://www.tempus.com/publications/identifying-biomarkers-associated-with-disease-free-survival-in-early-stage-lung-cancer/ 2022-11-22T23:02:16+00:00 https://www.tempus.com/publications/operational-metrics-for-the-elaine-ii-study-combining-a-traditional-approach-with-a-just-in-time-model/ 2022-11-22T23:02:23+00:00 https://www.tempus.com/publications/genetic-ancestry-differences-in-tumor-mutation-and-expression-in-early-and-average-onset-colorectal-cancer/ 2022-11-22T23:02:30+00:00 https://www.tempus.com/publications/paired-tumor-normal-sequencing-reduces-apparent-racial-differences-in-tumor-mutational-burden-tmb/ 2022-11-22T23:02:38+00:00 https://www.tempus.com/publications/real-world-data-enables-large-scale-assessment-of-who-cns5-glioma-classification/ 2022-11-22T23:02:55+00:00 https://www.tempus.com/publications/genetic-ancestry-correlates-of-the-cancer-somatic-mutational-landscape-from-tumor-profiling-data-of-50000-cancer-patients/ 2022-11-22T23:03:10+00:00 https://www.tempus.com/publications/clinical-rna-sequencing-improves-the-detection-of-actionable-fusions-over-dna-sequencing-alone/ 2022-11-22T23:03:18+00:00 https://www.tempus.com/publications/impact-of-ras-mutations-on-immunologic-characteristics-of-the-tumor-microenvironment-tme-in-patients-with-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-colorect/ 2022-11-22T23:03:26+00:00 https://www.tempus.com/publications/prevalence-of-high-tumor-mutational-burden-tmb-h-and-microsatellite-instability-high-msi-h-status-in-neuroendocrine-neoplasms/ 2022-11-22T23:03:34+00:00 https://www.tempus.com/publications/genomic-landscape-of-smarca4-deficient-lung-tumors-by-clinical-rna-sequencing/ 2022-11-22T23:03:43+00:00 https://www.tempus.com/publications/dual-tissue-and-plasma-testing-improves-detection-of-actionable-variants-in-patients-with-solid-cancers/ 2022-11-22T23:04:16+00:00 https://www.tempus.com/publications/ai-based-predictive-and-diagnostic-electrocardiography/ 2022-11-22T23:04:24+00:00 https://www.tempus.com/publications/privacy-preserving-validation-for-multiomic-prediction-models/ 2022-11-22T23:04:33+00:00 https://www.tempus.com/publications/ai-augmented-histopathologic-review-using-image-analysis-to-optimize-dna-yield-and-tumor-purity-from-ffpe-slides/ 2022-11-22T23:04:43+00:00 https://www.tempus.com/publications/phase-2-single-arm-study-of-nivolumab-and-ipilimumab-nivo-ipi-in-previously-treated-classical-kaposi-sarcoma-cks/ 2022-11-22T23:04:50+00:00 https://www.tempus.com/publications/accurate-genotyping-of-ugt1a1-dinucleotide-repeat-polymorphism-from-targeted-ngs-data-for-the-assessment-of-irinotecan-chemotherapy-adverse-events/ 2022-11-22T23:04:59+00:00 https://www.tempus.com/publications/case-report-awake-craniotomy-during-pregnancy-for-resection-of-glioblastoma/ 2022-11-22T23:05:21+00:00 https://www.tempus.com/publications/effects-of-color-calibration-via-icc-profile-on-inter-scanner-generalization-of-ai-models/ 2022-11-22T23:05:29+00:00 https://www.tempus.com/publications/assessing-variability-across-hrd-assays-findings-from-the-friends-hrd-harmonization-project/ 2022-11-22T23:45:09+00:00 https://www.tempus.com/publications/the-genomic-and-immune-landscape-of-osteosarcoma/ 2022-11-23T00:08:43+00:00 https://www.tempus.com/publications/prevalence-of-pharmacogenomic-actionability-in-11000-patients-receiving-psychiatric-care/ 2022-11-23T01:15:52+00:00 https://www.tempus.com/publications/symptom-tracking-using-tempuspro-in-patients-with-pharmacogenetic-testing-from-a-real-world-dataset/ 2022-11-23T01:23:21+00:00 https://www.tempus.com/publications/regulation-of-oncogenic-transcription-and-tumor-growth-in-pediatric-cancers-by-the-cdk9-inhibitor-kb-0742/ 2022-11-23T01:29:18+00:00 https://www.tempus.com/publications/targeted-next-generation-sequencing-ngs-of-temporally-matched-cerebrospinal-fluid-csf-and-tumor-tissue-in-patients-with-recurrent-glioblastoma-gbm/ 2022-12-05T17:48:09+00:00 https://www.tempus.com/publications/association-between-patient-reported-sleep-quality-and-passive-sleep-measurements-in-patients-with-psychiatric-disorders-using-mobile-based-questionnaires-and-wearable-sensors/ 2022-12-05T17:48:16+00:00 https://www.tempus.com/publications/the-genomic-transcriptomic-and-epigenomic-landscape-of-isocitrate-dehydrogenase-wild-type-glioblastoma-across-the-age-continuum/ 2022-12-05T17:48:23+00:00 https://www.tempus.com/news/tempus-announces-six-abstracts-accepted-for-poster-presentation-at-the-2022-san-antonio-breast-cancer-symposium/ 2022-12-06T14:00:52+00:00 https://www.tempus.com/resources/content/articles/patient-recruitment-at-the-speed-of-science/ 2022-12-07T16:00:10+00:00 https://www.tempus.com/wp-content/uploads/2022/09/Tempus-articles_ELAINE-2.png https://www.tempus.com/publications/an-ecg-based-machine-learning-model-for-predicting-new-onset-atrial-fibrillation-is-superior-to-age-and-clinical-features-in-identifying-patients-at-high-stroke-risk/ 2022-12-07T20:42:29+00:00 https://www.tempus.com/news/md-anderson-cancer-center/ 2022-12-08T15:08:55+00:00 https://www.tempus.com/news/milken-institutes-future-of-health/ 2022-12-13T14:45:25+00:00 https://www.tempus.com/news/fight-colorectal-cancer-funds-tempus-research-fellow-to-identify-gaps-in-colorectal-cancer-research/ 2022-12-15T14:30:13+00:00 https://www.tempus.com/news/tempus-announces-prospective-study-for-biomarker-discovery-in-small-cell-lung-cancer/ 2023-01-05T15:06:44+00:00 https://www.tempus.com/news/university-of-california-los-angeles/ 2023-01-11T16:13:05+00:00 https://www.tempus.com/publications/actionable-genomic-landscapes-from-a-real-world-cohort-of-urothelial-carcinoma-patients/ 2023-01-18T17:28:03+00:00 https://www.tempus.com/publications/comparative-analysis-of-tumor-immune-microenvironment-in-primary-tumors-vs-metastatic-tissue-in-microsatellite-stable-metastatic-colorectal-cancer/ 2023-01-22T14:02:19+00:00 https://www.tempus.com/publications/comprehensive-characterization-of-kras-mutations-and-inter-relation-with-primary-tumor-location-in-colorectal-cancers/ 2023-01-22T14:00:38+00:00 https://www.tempus.com/publications/characterizing-the-genomic-landscape-of-pole-pold1-mutated-colorectal-adenocarcinoma/ 2023-01-22T14:00:27+00:00 https://www.tempus.com/publications/prospective-basecamp-1-experience-in-patients-with-gastrointestinal-gi-cancer-identifying-patients-with-human-leukocyte-antigen-hla-loss-of-heterozygosity-loh-for-a-future-therapeutic-trial-exp/ 2023-01-22T14:00:17+00:00 https://www.tempus.com/resources/content/blog/precision-medicine-made-real-enhancing-genetic-testing-with-ai-algorithms/ 2023-02-12T18:50:55+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Stumpe.jpg https://www.tempus.com/resources/content/blog/my-takeaways-advancing-equitable-cancer-care-through-innovation-at-the-2022-american-society-of-clinical-oncology-asco-annual-meeting/ 2023-02-12T18:52:00+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Chen.jpg https://www.tempus.com/resources/content/blog/enhancing-first-line-treatment-for-colorectal-cancer-with-genomic-profiling-and-predictive-diagnostics/ 2023-02-12T18:53:44+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/blog/my-takeaways-the-2022-american-association-for-cancer-researchs-annual-meeting/ 2023-02-12T18:53:53+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/blog/advancing-immunotherapy-in-oncology/ 2023-02-12T18:54:37+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/blog/reflections-on-the-2021-san-antonio-breast-cancer-symposium-harnessing-the-power-of-data-to-advance-breast-cancer-research-and-benefit-patients/ 2023-02-12T18:54:57+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/blog/improving-mental-health-outcomes-through-personalized-medicine/ 2023-02-12T18:55:23+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/blog/a-patient-centric-approach-to-transforming-healthcare/ 2023-02-12T18:55:37+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/blog/welcome-arterys-integrating-medical-imaging-insights-to-drive-better-outcomes-for-patients/ 2023-02-12T18:59:41+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fukushima.jpg https://www.tempus.com/publications/genomic-and-immune-landscape-of-erbb2-erbb3-alterations-in-gastroesophageal-adenocarcinoma/ 2023-02-12T18:59:58+00:00 https://www.tempus.com/publications/real-world-outcome-analysis-of-patients-with-advanced-gastric-and-gastroesophageal-adenocarcinoma-with-her2-low-expression-treated-with-first-line-therapy/ 2023-02-12T19:00:30+00:00 https://www.tempus.com/resources/content/webinars/role-of-ctdna-in-germline-testing/ 2023-02-12T19:07:44+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep5-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/operational-processes-and-challenges/ 2023-02-12T19:08:03+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep6-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/experience-with-interpreting-somatic-reports/ 2023-02-12T19:08:19+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep3-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/tumor-normal-matched-sequencing-and-platforms-utilized-for-tumor-profiling/ 2023-02-12T19:08:38+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep2-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/defining-germline-sequencing-and-incidental-germline-findings-july-22-2021/ 2023-02-12T19:08:54+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep1-onclive-preview.jpeg https://www.tempus.com/publications/molecular-characteristics-of-advanced-clear-cell-renal-cell-carcinoma-ccrcc-harboring-tert-mutations/ 2023-02-19T14:00:24+00:00 https://www.tempus.com/publications/homologous-recombination-repair-hrr-mutation-concordance-between-liquid-biopsy-lb-and-tumor-tissue-by-ngs-in-a-real-world-prostate-cancer-pc-database/ 2023-02-19T14:00:06+00:00 https://www.tempus.com/publications/pathogenic-braf-mutations-in-prostate-cancer-frequency-and-distribution/ 2023-02-19T14:00:47+00:00 https://www.tempus.com/publications/cdk12-pathogenic-mutations-in-african-american-and-white-patients-with-prostate-cancer/ 2023-02-19T14:00:14+00:00 https://www.tempus.com/publications/basecamp-1-leveraging-human-leukocyte-antigen-a-hla-a-loss-of-heterozygosity-loh-in-solid-tumors-by-next-generation-sequencing-ngs-to-identify-patients-with-relapsed-solid-tumors-for-carcinoemb/ 2023-02-26T14:00:38+00:00 https://www.tempus.com/publications/fibroblast-growth-factor-receptor-fgfr-aberrations-in-metastatic-non-small-cell-lung-cancer-mnsclc-an-analysis-of-prevalence-and-a-potential-therapeutic-target-for-resistance-to-epidermal-growth/ 2023-02-26T14:00:44+00:00 https://www.tempus.com/resources/content/webinars/identification-of-patients-for-germline-testing/ 2023-02-20T14:52:47+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep4-onclive-preview.jpeg https://www.tempus.com/resources/content/articles/tempus-led-research-paper-in-nature-integration-of-tumor-extrinsic-and-intrinsic-features-associates-with-immunotherapy-response-in-non-small-cell-lung-cancer/ 2023-02-20T19:36:24+00:00 https://www.tempus.com/wp-content/uploads/2022/09/Tempus-articles_Nature-Commv2.png https://www.tempus.com/wp-content/uploads/2022/09/Tempus-articles_Nature-Commv3.png https://www.tempus.com/news/tempus-announces-new-strategic-collaboration-with-pfizer-to-advance-oncology-therapeutic-development/ 2023-02-28T14:30:33+00:00 https://www.tempus.com/publications/real-world-data-validation-of-the-purist-pancreatic-ductal-adenocarcinoma-gene-expression-classifier-and-its-prognostic-implications/ 2023-02-24T22:28:57+00:00 https://www.tempus.com/news/tempus-introduces-taap-a-collaborative-research-platform-to-develop-and-deploy-algorithmic-diagnostics/ 2023-03-08T14:30:45+00:00 https://www.tempus.com/news/tempus-announces-the-acquisition-of-mpirik/ 2023-03-09T16:00:50+00:00 https://www.tempus.com/publications/homologous-recombination-deficiency-is-detectable-from-he-whole-slide-images-in-real-world-prostate-needle-core-biopsies/ 2023-03-15T21:30:07+00:00 https://www.tempus.com/publications/he-based-msi-predictor-generalizes-to-external-site-stain-and-scanner-characteristics/ 2023-03-15T21:30:09+00:00 https://www.tempus.com/publications/deep-learning-identifies-fgfr-alterations-from-he-whole-slide-images-in-bladder-cancer/ 2023-03-15T21:30:25+00:00 https://www.tempus.com/news/city-of-hope/ 2023-03-21T17:56:16+00:00 https://www.tempus.com/publications/development-and-validation-of-an-ngs-assay-for-the-detection-of-clinically-actionable-genetic-variants-in-dpyd-and-ugt1a1/ 2023-03-28T17:28:04+00:00 https://www.tempus.com/publications/detection-of-pancreatic-ductal-adenocarcinoma-basal-like-and-classical-subtypes-from-he-whole-slide-images/ 2023-03-28T20:20:17+00:00 https://www.tempus.com/news/tempus-announces-second-sequencing-collaboration-with-lilly-to-expand-patient-access-to-genomic-testing/ 2023-04-03T13:30:40+00:00 https://www.tempus.com/publications/racial-disparities-in-pathological-complete-response-among-patients-receiving-neoadjuvant-chemotherapy-for-early-stage-breast-cancer/ 2023-03-31T19:29:13+00:00 https://www.tempus.com/events/uscap-2023/ 2023-03-31T20:29:00+00:00 https://www.tempus.com/news/university-of-california-irvine/ 2023-04-03T15:31:27+00:00 https://www.tempus.com/resources/content/blog/leveraging-tempus-ai-and-multimodal-data-to-increase-probability-of-technical-success-in-biopharma/ 2023-04-04T21:09:13+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Huerga.jpg https://www.tempus.com/resources/content/blog/unlocking-the-value-of-rna-data/ 2023-04-04T21:18:42+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fukushima.jpg https://www.tempus.com/resources/content/case-studies/ultra-rapid-site-activation-and-subject-consent-in-parpi-study-using-tempus-time-program/ 2023-04-08T21:24:55+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-LS_Case-Study-TIME-Anonymous_PeaceHealth-Thumbnail.jpg https://www.tempus.com/resources/content/webinars/discover-novel-targets-and-applications-with-tempus-explore/ 2023-04-08T21:26:49+00:00 https://www.tempus.com/publications/qualitative-grading-of-aortic-regurgitation-a-pilot-study-comparing-cmr-4d-flow-and-echocardiography/ 2023-04-10T22:22:24+00:00 https://www.tempus.com/publications/asymptomatic-aortic-coarctation-diagnosed-because-of-large-abdominal-arterial-collateral/ 2023-04-10T22:45:53+00:00 https://www.tempus.com/publications/cloud-processed-4d-cmr-flow-imaging-for-pulmonary-flow-quantification/ 2023-04-10T23:01:38+00:00 https://www.tempus.com/publications/pelvic-blood-flow-predicts-fibroid-volume-and-embolic-required-for-uterine-fibroid-embolization-a-pilot-study-with-4d-flow-mr-angiography/ 2023-04-11T16:19:09+00:00 https://www.tempus.com/publications/systemic-artery-to-pulmonary-vein-fistula-after-right-upper-lobectomy-demonstrated-by-4-dimensional-flow-magnetic-resonance-imaging/ 2023-04-11T16:21:37+00:00 https://www.tempus.com/publications/evaluation-of-atrial-septal-defects-with-4d-flow-mri-multilevel-and-inter-reader-reproducibility-for-quantification-of-shunt-severity/ 2023-04-11T16:37:36+00:00 https://www.tempus.com/uncategorized/innovative-multi-modality-imaging-to-assess-paravalvular-leak/ 2023-04-11T16:40:29+00:00 https://www.tempus.com/publications/validation-of-4d-flow-cmr-against-simultaneous-invasive-hemodynamic-measurements-a-swine-study/ 2023-04-11T16:42:51+00:00 https://www.tempus.com/publications/changes-in-segmental-pulse-wave-velocity-of-the-thoracic-aorta-with-age-and-left-ventricular-remodelling-an-mri-4d-flow-study/ 2023-04-11T16:46:44+00:00 https://www.tempus.com/publications/neopulmonary-outflow-tract-obstruction-assessment-by-4d-flow-mri-in-adults-with-transposition-of-the-great-arteries-after-arterial-switch-operation/ 2023-04-11T17:03:36+00:00 https://www.tempus.com/publications/false-lumen-ejection-fraction-predicts-growth-in-type-b-aortic-dissection-preliminary-results/ 2023-04-11T17:08:33+00:00 https://www.tempus.com/publications/4d-flow-vs-2d-cardiac-mri-for-the-evaluation-of-pulmonary-regurgitation-and-ventricular-volume-in-repaired-tetralogy-of-fallot-a-retrospective-case-control-study/ 2023-04-11T17:13:09+00:00 https://www.tempus.com/publications/fluid-structure-interaction-simulations-of-patient-specific-aortic-dissection/ 2023-04-11T17:22:40+00:00 https://www.tempus.com/publications/deep-learning-single-frame-and-multiframe-super-resolution-for-cardiac-mri/ 2023-04-11T17:27:14+00:00 https://www.tempus.com/publications/evaluation-of-cardiac-shunts-with-4d-flow-cardiac-magnetic-resonance-intra-and-interobserver-variability/ 2023-04-11T17:31:57+00:00 https://www.tempus.com/publications/comprehensive-motion-compensated-highly-accelerated-4d-flow-mri-with-ferumoxytol-enhancement-for-pediatric-congenital-heart-disease/ 2023-04-12T15:44:09+00:00 https://www.tempus.com/news/tempus-announces-seven-abstracts-accepted-for-presentation-at-the-american-association-for-cancer-research-annual-meeting-2023/ 2023-04-14T14:28:09+00:00 https://www.tempus.com/publications/assessment-of-the-precision-and-reproducibility-of-ventricular-volume-function-and-mass-measurements-with-ferumoxytol-enhanced-4d-flow-mri/ 2023-04-14T14:36:52+00:00 https://www.tempus.com/publications/free-breathing-pediatric-chest-mri-performance-of-self-navigated-golden-angle-ordered-conical-ultrashort-echo-time-acquisition/ 2023-04-14T14:39:41+00:00 https://www.tempus.com/publications/4d-flow-mri-quantification-of-mitral-and-tricuspid-regurgitation-reproducibility-and-consistency-relative-to-conventional-mri/ 2023-04-14T14:40:27+00:00 https://www.tempus.com/publications/volumetric-segmentation-free-method-for-rapid-visualization-of-vascular-wall-shear-stress-using-4d-flow-mri/ 2023-04-14T14:40:36+00:00 https://www.tempus.com/publications/4d-flow-image-quality-with-blood-pool-contrast-a-comparison-of-gadofosveset-trisodium-and-ferumoxytol/ 2023-04-14T14:40:48+00:00 https://www.tempus.com/publications/clinical-use-of-4d-flow-mri-for-quantification-of-aortic-regurgitation/ 2023-04-14T14:42:00+00:00 https://www.tempus.com/publications/pediatric-rectal-adenocarcinoma-with-mismatch-repair-deficiency-responds-to-immunotherapy/ 2023-04-14T21:03:58+00:00 https://www.tempus.com/news/northwestern-university-baylor-university-cedar-sinai-university-of-pittsburgh/ 2023-04-19T13:30:33+00:00 https://www.tempus.com/news/pr/nature-biotechnology-study-reveals-that-tempus-xt-platform-increases-cancer-patients-personalized-therapeutic-opportunities/ 2023-04-19T03:21:00+00:00 https://www.tempus.com/news/forbes-3/ 2023-04-21T14:41:38+00:00 https://www.tempus.com/publications/validation-of-a-transcriptome-based-assay-for-classifying-cancers-of-unknown-primary-origin-2/ 2023-04-26T15:44:09+00:00 https://www.tempus.com/publications/contrived-materials-and-a-data-set-for-the-evaluation-of-liquid-biopsy-tests-a-blood-profiling-atlas-in-cancer-bloodpac-community-study/ 2023-04-26T16:03:45+00:00 https://www.tempus.com/publications/ancestry-associated-differences-in-somatic-mutation-rates-from-tumor-profiling-data-of-a-pan-cancer-cohort-of-100000-patients/ 2023-05-01T17:24:49+00:00 https://www.tempus.com/publications/leveraging-scale-in-precision-oncology-to-measure-pathway-activation-and-detect-genetic-drivers-in-a-large-real-world-pan-cancer-cohort/ 2023-05-01T17:25:31+00:00 https://www.tempus.com/publications/pavo-a-phase-ii-open-label-single-arm-study-of-niraparib-in-patients-with-locally-advanced-metastatic-palb2-mutated-tumors/ 2023-05-01T17:27:02+00:00 https://www.tempus.com/publications/racial-disparities-in-comprehensive-cancer-tumor-profiling-testing-from-real-world-data-of-100000-cancer-patient-records/ 2023-05-01T17:27:27+00:00 https://www.tempus.com/publications/using-computer-vision-to-resolve-proliferative-dynamics-within-therapeutic-responses-in-large-scale-screens-of-patient-derived-models/ 2023-05-01T17:28:23+00:00 https://www.tempus.com/news/tempus-receives-u-s-fda-approval-for-xt-cdx-a-ngs-based-in-vitro-diagnostic-device/ 2023-05-01T18:42:19+00:00 https://www.tempus.com/publications/assessment-of-tumor-mutational-burden-and-outcomes-in-patients-with-diverse-advanced-cancers-treated-with-immunotherapy/ 2023-05-03T17:10:02+00:00 https://www.tempus.com/news/tempus-announces-dr-ezra-cohen-as-chief-medical-officer-of-oncology/ 2023-05-09T12:30:19+00:00 https://www.tempus.com/news/tempus-announces-dr-ned-sharpless-as-a-senior-strategic-advisor/ 2023-05-10T12:30:11+00:00 https://www.tempus.com/resources/content/case-studies/using-time-to-accelerate-trial-enrollment-for-aadi-bioscience/ 2023-05-15T16:34:54+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-LS_Case-Study-Aadi-Bioscience.png https://www.tempus.com/publications/genomic-markers-of-cdk-4-6-inhibitor-resistance-in-hormone-receptor-positive-metastatic-breast-cancer/ 2023-05-19T16:01:45+00:00 https://www.tempus.com/publications/molecular-profiling-of-a-real-world-breast-cancer-cohort-with-genetically-inferred-ancestries-reveals-actionable-tumor-biology-differences-between-european-ancestry-and-african-ancestry-patient-popula/ 2023-05-25T15:12:40+00:00 https://www.tempus.com/news/tempus-announces-broad-launch-of-tempus-one/ 2023-06-01T15:34:39+00:00 https://www.tempus.com/news/tempus-exhibits-20-abstracts-at-the-2023-american-society-of-clinical-oncology-annual-meeting/ 2023-06-02T13:30:02+00:00 https://www.tempus.com/publications/association-of-molecular-profiles-of-head-and-neck-squamous-cell-carcinoma-with-heterogeneity-across-racial-ethnic-groups-in-the-united-states/ 2023-06-01T20:10:31+00:00 https://www.tempus.com/publications/identification-of-a-novel-class-of-early-exon-alk-rearrangements-across-two-pan-tumor-sequencing-databases/ 2023-06-01T20:14:57+00:00 https://www.tempus.com/publications/genomic-characterization-of-vulvar-squamous-cell-carcinoma-to-reveal-differential-gene-expression-based-on-clinical-outcome/ 2023-06-01T20:19:05+00:00 https://www.tempus.com/publications/patient-characteristics-treatment-patterns-and-clinical-outcomes-among-patients-with-de-novo-advanced-or-metastatic-stage-iiib-iv-non-small-cell-lung-cancer-in-a-real-world-setting/ 2023-06-01T20:22:26+00:00 https://www.tempus.com/publications/analysis-on-real-world-chemotherapy-outcomes-in-patients-pts-with-tyrosine-kinase-inhibitor-tki-resistant-advanced-egfr-mutant-non-small-cell-lung-cancer-nsclc-in-the-united-states/ 2023-06-01T20:26:27+00:00 https://www.tempus.com/publications/rna-sequencing-to-characterize-pathways-in-egfr-mutated-non-small-cell-lung-cancer/ 2023-06-01T20:29:08+00:00 https://www.tempus.com/publications/next-generation-sequencing-ngs-testing-for-cancer-patients-at-a-safety-net-hospital/ 2023-06-01T21:14:04+00:00 https://www.tempus.com/publications/renal-cell-carcinoma-with-metastasis-to-the-pancreas-genomic-signatures-and-clinical-outcomes/ 2023-06-01T21:17:17+00:00 https://www.tempus.com/publications/association-of-tumor-homologous-recombination-deficiency-hrd-score-with-immune-checkpoint-inhibitor-benefit-in-metastatic-clear-cell-renal-cell-carcinoma/ 2023-06-01T21:20:13+00:00 https://www.tempus.com/publications/clinical-outcomes-among-patients-with-advanced-non-small-cell-lung-cancer-who-received-targeted-therapy-in-a-real-world-setting/ 2023-06-01T21:22:55+00:00 https://www.tempus.com/publications/integrated-clinical-pathologic-and-genetic-data-in-a-racially-diverse-hereditary-breast-cancer-cohort/ 2023-06-01T21:31:09+00:00 https://www.tempus.com/publications/pathway-enrichment-analysis-in-tumors-with-high-mutation-burdens-and-interferon-g-signature-expression-a-pan-cancer-analysis/ 2023-06-01T21:35:53+00:00 https://www.tempus.com/publications/characterizing-the-landscape-of-ring-type-e3-ubiquitin-transferase-altered-rnf43-alt-colorectal-cancer-crc-and-defining-unique-subsets-with-potential-therapeutic-vulnerabilities-in-microsatellite/ 2023-06-07T20:06:50+00:00 https://www.tempus.com/publications/germline-alterations-in-patients-with-lung-cancer/ 2023-06-07T20:07:25+00:00 https://www.tempus.com/publications/genomic-comparison-of-met-exon-14-skipping-and-met-amplified-non-small-cell-lung-cancer/ 2023-06-07T20:08:08+00:00 https://www.tempus.com/publications/the-tempus-time-trial-portal-and-clinical-trial-enrollment/ 2023-06-07T20:08:34+00:00 https://www.tempus.com/publications/evaluation-of-microsatellite-instability-status-a-definitive-predictive-biomarker-for-immune-checkpoint-inhibitors-ici-in-underrepresented-minorities-urm-with-gastrointestinal-gi-cancers/ 2023-06-07T20:10:19+00:00 https://www.tempus.com/publications/real-world-response-endpoints-in-patients-with-mnsclc-treated-with-chemotherapy-across-real-world-datasets/ 2023-06-07T20:11:18+00:00 https://www.tempus.com/publications/effect-of-germline-mutations-on-somatic-alteration-landscapes-in-brca-associated-cancers/ 2023-06-07T20:12:11+00:00 https://www.tempus.com/publications/germline-mutations-and-the-presence-of-clonal-hematopoiesis-of-indeterminate-potential-chip-in-20963-patients-with-brca-associated-cancers/ 2023-06-07T20:13:39+00:00 https://www.tempus.com/publications/real-world-outcomes-of-first-line-immune-checkpoint-inhibitors-with-or-without-chemotherapy-in-kras-g12c-altered-nsclc-according-to-pd-l1-status/ 2023-06-07T20:15:26+00:00 https://www.tempus.com/publications/associations-between-androgen-directed-treatments-and-ar-mutational-landscapes-in-the-circulating-tumor-dna-of-a-real-world-metastatic-prostate-cancer-cohort/ 2023-06-07T20:16:08+00:00 https://www.tempus.com/publications/molecular-diagnostic-classification-for-cancers-of-unknown-primary-cup-post-testing-diagnosis-and-treatment-impact-analysis-from-real-world-claims-data/ 2023-06-07T20:17:42+00:00 https://www.tempus.com/publications/genomic-landscapes-of-early-onset-versus-average-onset-colorectal-cancer-populations/ 2023-06-07T20:18:25+00:00 https://www.tempus.com/publications/homologous-recombination-deficiency-hrd-in-non-small-cell-lung-cancer-genomic-analysis-using-an-rna-based-hrd-algorithm/ 2023-06-07T20:19:20+00:00 https://www.tempus.com/news/tempus-announces-new-multi-omics-collaboration-with-actuate-therapeutics/ 2023-06-07T20:32:37+00:00 https://www.tempus.com/news/ucla-mattel-childrens-hospital/ 2023-06-08T16:19:51+00:00 https://www.tempus.com/publications/machine-learning-analysis-including-social-determinants-of-health-for-predication-of-mortality-following-transcatheter-aortic-valve-implantation-a-single-center-experience/ 2023-06-14T16:15:59+00:00 https://www.tempus.com/publications/echocardiographic-and-socioeconomic-predictors-of-progression-of-moderate-tricuspid-regurgitation-a-single-center-study/ 2023-06-14T16:17:01+00:00 https://www.tempus.com/publications/enhanced-detection-of-heart-valve-disease-using-integrated-artificial-intelligence-at-scale/ 2023-06-14T16:26:15+00:00 https://www.tempus.com/publications/machine-learning-analysis-of-progression-from-moderate-to-severe-tricuspid-regurgitation/ 2023-06-15T17:09:58+00:00 https://www.tempus.com/publications/machine-learning-based-cluster-analysis-of-patients-with-significant-tricuspid-regurgitation-reveals-distinct-population-with-different-phenotypes-and-clinical-outcomes/ 2023-06-15T17:39:41+00:00 https://www.tempus.com/news/tempus-launches-standalone-rna-sequencing-test-xr/ 2023-06-21T13:08:46+00:00 https://www.tempus.com/publications/operational-metrics-for-the-elaine-2-study-combining-a-traditional-approach-with-a-just-in-time-model/ 2023-06-26T15:44:56+00:00 https://www.tempus.com/news/roswell-park-comprehensive-cancer-center/ 2023-06-26T21:44:44+00:00 https://www.tempus.com/publications/pharmacogenomic-actionability-in-15000-patients-with-next-generation-sequencing-enabled-copy-number-variation-and-novel-haplotype-detection/ 2023-06-27T19:33:38+00:00 https://www.tempus.com/publications/association-between-mobile-based-patient-reported-sleep-questionnaires-and-passive-wearable-sleep-sensors-in-psychiatry-patients/ 2023-06-27T19:43:29+00:00 https://www.tempus.com/resources/content/articles/dual-testing-in-metastatic-breast-cancer/ 2023-06-28T14:34:44+00:00 https://www.tempus.com/wp-content/uploads/2022/11/Resources_web-assets_Tempus-articles_JCO-Precision-Onco.png https://www.tempus.com/wp-content/uploads/2023/06/Figure-1-Revised.png https://www.tempus.com/wp-content/uploads/2023/06/Figure-2-Revised.png https://www.tempus.com/wp-content/uploads/2022/11/Resources_web-assets_Tempus-articles_JCO-Precision-Onco-Thumb.png https://www.tempus.com/publications/applying-machine-vision-to-empower-preclinical-development-of-cell-engager-and-adoptive-cell-therapeutics-in-patient-derived-organoid-models-of-solid-tumors/ 2023-06-30T19:29:54+00:00 https://www.tempus.com/news/tempus-announces-companion-diagnostic-collaboration-with-tscan-therapeutics/ 2023-07-06T13:30:30+00:00 https://www.tempus.com/publications/clinical-and-genomic-characteristics-of-patients-with-hr-her2-metastatic-breast-cancer-following-progression-on-a-cdk4-and-6-inhibitor/ 2023-07-05T22:17:35+00:00 https://www.tempus.com/news/tempus-announces-the-gemini-non-small-cell-lung-cancer-study/ 2023-07-12T13:30:50+00:00 https://www.tempus.com/publications/determining-parp-inhibition-as-a-treatment-strategy-in-melanoma-based-on-homologous-recombination-deficiency-related-loss-of-heterozygosity/ 2023-07-14T15:37:40+00:00 https://www.tempus.com/news/fda-grants-breakthrough-device-designation-to-tempus-hla-loh-companion-diagnostic-test/ 2023-08-15T13:30:19+00:00 https://www.tempus.com/news/tempus-welcomes-unc-lineberger-comprehensive-cancer-center-to-tempus-plus-community/ 2023-08-22T15:41:45+00:00 https://www.tempus.com/publications/neratinib-fulvestrant-trastuzumab-for-hr-positive-her2-negative-her2-mutant-metastatic-breast-cancer-outcomes-and-biomarker-analysis-from-the-summit-trial/ 2023-08-23T22:39:50+00:00 https://www.tempus.com/publications/overcoming-the-challenges-of-variant-calling-in-pms2-high-homology-regions-for-improved-lynch-syndrome-diagnosis-using-whole-genome-sequencing/ 2023-08-28T15:23:55+00:00 https://www.tempus.com/wp-content/uploads/2023/07/1.png https://www.tempus.com/wp-content/uploads/2023/07/2.png https://www.tempus.com/events/dpharm-2023/ 2023-09-12T16:09:29+00:00 https://www.tempus.com/events/ras-drug-development-2023/ 2023-09-12T16:10:45+00:00 https://www.tempus.com/events/tumormodels2023/ 2023-09-12T16:12:44+00:00 https://www.tempus.com/events/13th-annual-world-clinical-biomarkers-cdx-summit/ 2023-09-12T16:21:00+00:00 https://www.tempus.com/events/next-generation-dx2023/ 2023-09-12T16:21:20+00:00 https://www.tempus.com/events/mrna-based-therapeutics2023/ 2023-09-12T16:25:42+00:00 https://www.tempus.com/events/asco-gu-2023/ 2023-09-12T16:26:23+00:00 https://www.tempus.com/events/asco-gi-2023/ 2023-09-12T16:26:49+00:00 https://www.tempus.com/events/sabcs-2022/ 2023-09-12T16:27:12+00:00 https://www.tempus.com/events/aha-2022/ 2023-09-12T16:27:36+00:00 https://www.tempus.com/events/asco-2022/ 2023-09-12T16:27:53+00:00 https://www.tempus.com/events/fierce-clinical-summit-2023/ 2023-09-13T19:52:34+00:00 https://www.tempus.com/publications/prevalence-of-kras-subtype-alterations-in-non-small-cell-lung-cancer-nsclc-with-brain-metastases/ 2023-09-14T16:45:25+00:00 https://www.tempus.com/publications/racial-diversity-and-co-mutational-analysis-of-biologically-relevant-alterations-in-egfr-mutant-lung-cancers/ 2023-09-14T16:45:54+00:00 https://www.tempus.com/publications/assessing-the-utility-of-molecular-diagnostic-classification-for-cancers-of-unknown-primary/ 2023-09-15T16:52:41+00:00 https://www.tempus.com/events/spatial-bio-drug-development-2023/ 2023-09-19T15:05:03+00:00 https://www.tempus.com/resources/content/spotlights/accelerate-the-growth-of-your-clinical-research-program-through-a-time-crc/ 2023-09-20T15:28:47+00:00 https://www.tempus.com/events/biotechx-europe-2023/ 2023-09-20T21:36:57+00:00 https://www.tempus.com/publications/real-world-treatment-patterns-and-sequencing-in-patients-with-locally-advanced-or-metastatic-urothelial-cancer-la-muc-in-the-us/ 2023-10-02T15:40:24+00:00 https://www.tempus.com/publications/quantifying-the-impact-of-immune-history-and-variant-on-sars-cov-2-viral-kinetics-and-infection-rebound-a-retrospective-cohort-study/ 2023-10-02T21:07:22+00:00 https://www.tempus.com/events/world-adc-2023/ 2023-10-03T14:53:17+00:00 https://www.tempus.com/resources/content/videos/industry-expert-theater-presentation-from-the-2023-asco-annual-meeting/ 2023-10-03T19:11:12+00:00 https://www.tempus.com/wp-content/uploads/2023/06/Tempus_Videos_ASCO-IET.png https://www.tempus.com/publications/uncovering-molecular-differences-in-pancreatic-ductal-adenocarcinoma-tissues-from-black-and-white-patients-in-the-us/ 2023-10-03T21:25:38+00:00 https://www.tempus.com/publications/pre-radiotherapy-ctdna-liquid-biopsy-for-risk-stratification-of-oligometastatic-non-small-cell-lung-cancer/ 2023-10-04T16:09:45+00:00 https://www.tempus.com/publications/utility-of-rna-expression-to-determine-the-tissue-of-origin-of-malignancies-with-an-inconclusive-histopathology/ 2023-10-04T16:17:12+00:00 https://www.tempus.com/publications/a-deep-learning-based-rna-seq-germline-variant-caller-2/ 2023-10-04T16:20:09+00:00 https://www.tempus.com/publications/exploring-barriers-to-pediatric-cancer-clinical-trials-the-role-of-a-networked-just-in-time-study-program/ 2023-10-04T16:26:18+00:00 https://www.tempus.com/news/stanford-university/ 2023-10-04T16:49:12+00:00 https://www.tempus.com/resources/content/videos/aacr-gsk-product-theater/ 2023-10-05T14:27:22+00:00 https://www.tempus.com/wp-content/uploads/2023/06/Tempus_Videos_GSK-AACR.png https://www.tempus.com/resources/content/videos/clinical-utility-of-tumor-normal-matched-sequencing/ 2023-10-05T14:28:06+00:00 https://www.tempus.com/wp-content/uploads/2023/03/Tempus-videos_TumorNormal-Thumb.png https://www.tempus.com/resources/content/videos/product-theatre-presentation-from-the-2022-sabcs-annual-meeting/ 2023-10-05T14:28:36+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Videos_SABCS-Product-Theatre.png https://www.tempus.com/resources/content/videos/pharmacogenomics-serotonin-transporter-gene/ 2023-10-05T14:28:57+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_nP-Explainer-Videos.png https://www.tempus.com/resources/content/videos/pharmacogenomics-adhd/ 2023-10-05T14:29:11+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_nP-Explainer-Videos.png https://www.tempus.com/resources/content/videos/pharmacogenomics-treatment-resistant-depression/ 2023-10-05T14:29:24+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_nP-Explainer-Videos.png https://www.tempus.com/resources/content/videos/the-tempus-emerging-evidence-genes/ 2023-10-05T14:29:40+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_nP-Explainer-Videos.png https://www.tempus.com/resources/content/videos/physician-testimonial-from-dr-jeffrey-james-of-colorado-gynecologic-oncology-specialists/ 2023-10-05T14:29:58+00:00 https://www.tempus.com/wp-content/uploads/2022/08/Tempus-videos_Dr-James-Testimonialv2.png https://www.tempus.com/resources/content/videos/physician-testimonial-trihealth/ 2023-10-05T14:30:15+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-videos_Physician-Testimonial-Dr-Maher.png https://www.tempus.com/resources/content/videos/precision-oncology-now/ 2023-10-05T14:30:33+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_Precision-Oncology-Now.png https://www.tempus.com/resources/content/case-studies/accelerate-trial-enrollment-with-time/ 2023-10-05T14:34:49+00:00 https://www.tempus.com/wp-content/uploads/2022/12/Tempus-LS_Case-Study_Elaine-II-Sermonix.png https://www.tempus.com/resources/content/case-studies/sequencing-for-development-and-commercialization/ 2023-10-05T14:36:47+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Seq.png https://www.tempus.com/resources/content/case-studies/powering-discovery-tempus-multimodal-database/ 2023-10-05T14:37:03+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Elaine-II.png https://www.tempus.com/resources/content/case-studies/how-to-identify-unmet-medical-need-with-tempus-rwd/ 2023-10-05T14:37:17+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Explore.png https://www.tempus.com/resources/content/case-studies/enhanced-biomarker-discovery-and-design/ 2023-10-05T14:37:32+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Seq-Data.png https://www.tempus.com/publications/circulating-tumor-dna-for-early-risk-stratification-of-oligometastatic-lung-cancer/ 2023-10-05T20:30:13+00:00 https://www.tempus.com/events/asco-2023/ 2023-10-12T13:54:18+00:00 https://www.tempus.com/news/tempus-announces-five-abstracts-accepted-for-presentation-at-the-european-society-for-medical-oncology-congress-2023/ 2023-10-20T13:30:29+00:00 https://www.tempus.com/resources/content/case-studies/pgx-case-for-mdd-gad-patient_hypothetical/ 2023-10-20T14:32:32+00:00 https://www.tempus.com/wp-content/uploads/2022/09/Tempus-LS_Case-Study-Depression.png https://www.tempus.com/publications/real-world-data-analysis-of-genomic-profiling-matched-targeted-therapy-outcomes-in-patients-with-fusion-positive-nsclc/ 2023-10-25T14:46:09+00:00 https://www.tempus.com/publications/genomic-characterization-of-sporadic-met-amplified-non-small-cell-lung-cancer-nsclc-and-association-with-real-world-outcomes/ 2023-10-25T14:49:03+00:00 https://www.tempus.com/publications/avelumab-first-line-maintenance-1lm-for-locally-advanced-or-metastatic-urothelial-carcinoma-la-muc-treatment-tx-patterns-and-real-world-rw-outcomes-in-the-us/ 2023-10-25T14:51:53+00:00 https://www.tempus.com/publications/comparative-analysis-of-the-tumor-immune-microenvironment-time-in-primary-and-metastatic-sites-of-microsatellite-stable-mss-and-microsatellite-instability-high-msi-colorectal-cancer/ 2023-10-25T14:54:26+00:00 https://www.tempus.com/publications/alk-fusion-detection-by-rna-next-generation-sequencing-ngs-compared-to-dna-in-a-large-real-world-non-small-cell-lung-cancer-nsclc-dataset/ 2023-10-25T14:57:23+00:00 https://www.tempus.com/publications/predictors-of-tricuspid-regurgitation-progression-and-follow-up-echo-imaging-an-artificial-intelligence-enhanced-study/ 2023-10-27T20:13:07+00:00 https://www.tempus.com/publications/multi-state-modeling-of-tricuspid-regurgitation-disease-progression-rate-using-an-ehr-integrated-natural-language-processing-platform/ 2023-10-27T20:18:07+00:00 https://www.tempus.com/news/tempus-announces-eight-abstracts-accepted-for-presentation-at-the-2023-society-for-immunotherapy-of-cancer-annual-meeting/ 2023-11-01T14:57:24+00:00 https://www.tempus.com/publications/everest-1-a-seamless-phase-1-2-study-of-cea-logic-gated-tmod-car-t-cell-therapy-a2b530-in-patients-with-solid-tumors-associated-with-cea-expression-also-exhibiting-hla-loss-of-heterozygosity-loh/ 2023-11-06T16:58:54+00:00 https://www.tempus.com/publications/basecamp-1-a-master-prescreening-study-to-identify-patients-with-high-risk-or-metastatic-solid-tumors-with-hla-loss-of-heterozygosity-loh-in-preparation-for-tmod-car-t-cell-therapy-trials/ 2023-11-06T16:59:33+00:00 https://www.tempus.com/publications/association-of-a-novel-circulating-tumor-fraction-dna-biomarker-of-treatment-response-monitoring-and-clinical-outcomes-in-a-real-world-diverse-pan-cancer-cohort-treated-with-immunotherapy/ 2023-11-06T17:01:20+00:00 https://www.tempus.com/publications/multimodal-real-world-data-reveals-immunogenomic-drivers-of-acquired-and-primary-resistance-to-immune-checkpoint-blockade/ 2023-11-06T17:02:53+00:00 https://www.tempus.com/publications/a-multi-modal-pan-cancer-atlas-of-tumor-immune-states-across-primary-and-metastatic-disease-using-a-large-real-world-database/ 2023-11-06T17:03:40+00:00 https://www.tempus.com/publications/racial-differences-in-ugt1a1-allele-frequencies-and-its-potential-impact-in-pharmacogenetic-testing-for-cancer-chemotherapy-drugs/ 2023-11-06T17:25:56+00:00 https://www.tempus.com/events/sitc-2023/ 2023-11-06T18:30:43+00:00 https://www.tempus.com/publications/overcoming-tumor-heterogeneity-clinical-trial-assays-to-prospectively-assign-patients-customized-multiplexed-tcr-t-cell-therapy-in-phase-1/ 2023-11-07T19:04:49+00:00 https://www.tempus.com/publications/interrogating-real-world-tumor-infiltrating-t-cell-repertoires-to-identify-antigen-enriched-tcrs-in-a-large-pan-cancer-clinical-cohort/ 2023-11-07T19:05:59+00:00 https://www.tempus.com/publications/genomic-characterization-of-chondrosarcoma-a-rare-sarcoma-with-clinical-responses-to-immune-checkpoint-inhibition/ 2023-11-07T19:23:45+00:00 https://www.tempus.com/news/tempus-announces-new-strategic-collaboration-with-recursion-to-advance-therapeutic-development/ 2023-11-09T14:00:46+00:00 https://www.tempus.com/news/tempus-announces-research-collaboration-with-bristol-myers-squibb-to-apply-multimodal-ai-approaches/ 2023-11-10T15:17:43+00:00 https://www.tempus.com/news/tempus-welcomes-rush-university-medical-center-to-tempus-plus-community/ 2023-11-14T17:20:05+00:00 https://www.tempus.com/news/tempus-welcomes-city-of-hope-comprehensive-cancer-center-to-tempus-plus-community/ 2023-11-20T15:18:54+00:00 https://www.tempus.com/publications/performance-of-copy-number-variant-detection-from-short-read-whole-genome-sequencing-for-clinical-gene-panel-applications/ 2023-11-21T18:28:59+00:00 https://www.tempus.com/publications/comparison-of-interassay-similarity-and-cellular-deconvolution-in-spatial-transcriptomics-data-using-visum-cytassist/ 2023-11-22T20:43:25+00:00 https://www.tempus.com/publications/performance-of-copy-number-variant-detection-tools-in-clinical-applications-a-comparative-benchmark-for-short-read-whole-genome-sequencing/ 2023-11-28T19:15:34+00:00 https://www.tempus.com/publications/the-mutational-landscape-of-1172-patients-with-hormone-receptor-positive-her2-negative-metastatic-breast-cancer-treated-with-cdk4-6-inhibitors/ 2023-11-28T19:16:55+00:00 https://www.tempus.com/publications/genomic-landscape-of-er-her2-metastatic-breast-cancer-as-a-function-of-prior-treatment-with-a-cdk4-6-inhibitor/ 2023-11-28T19:19:09+00:00 https://www.tempus.com/publications/clinico-molecular-real-world-data-demonstrates-prognostic-significance-of-a-three-gene-biomarker-for-colorectal-liver-oligometastases/ 2023-11-28T19:20:13+00:00 https://www.tempus.com/publications/purity-independent-subtyping-of-tumor-purist-real-world-data-validation-of-a-pancreatic-ductal-adenocarcinoma-pdac-gene-expression-classifier-and-its-prognostic-implications/ 2023-11-28T19:21:05+00:00 https://www.tempus.com/publications/gene-expression-and-mutation-profiles-in-her2-mutated-metastatic-breast-cancer/ 2023-11-28T19:24:20+00:00 https://www.tempus.com/publications/dual-ctdna-and-tissue-sequencing-improves-detection-of-actionable-variants-in-patients-with-breast-cancer/ 2023-11-28T19:26:03+00:00 https://www.tempus.com/publications/dora-a-phase-ii-multicenter-international-study-of-olaparib-with-or-without-durvalumab-as-a-chemotherapy-free-maintenance-strategy-in-platinum-pretreated-advanced-triple-negative-breast-cancer-tnb/ 2023-11-28T19:26:40+00:00 https://www.tempus.com/publications/molecular-characterization-of-her-2-low-patients-identifies-basal-enriched-subset-with-poor-clinical-outcomes-in-real-world-data/ 2023-11-28T19:27:38+00:00 https://www.tempus.com/news/personalis-and-tempus-enter-into-a-strategic-collaboration-to-advance-cancer-testing/ 2023-11-28T21:22:16+00:00 https://www.tempus.com/publications/radiogenomics-for-egfr-mutation-status-prediction-in-ct-images-impact-of-model-design-on-performance-and-prospective-generalizability/ 2023-12-01T19:43:44+00:00 https://www.tempus.com/wp-content/uploads/2023/11/rsna-fIGURE.png https://www.tempus.com/publications/real-world-evaluation-of-racial-and-socioeconomic-disparities-in-patients-with-nsclc-treated-with-immunotherapy/ 2023-12-04T16:27:59+00:00 https://www.tempus.com/uncategorized/large-language-models-with-retrieval-augmented-generation-for-zero-shot-disease-phenotyping/ 2023-12-17T19:14:42+00:00 https://www.tempus.com/publications/large-language-models-with-retrieval-augmented-generation-for-zero-shot-disease-phenotyping-2/ 2023-12-08T17:49:52+00:00 https://www.tempus.com/publications/rna-based-homologous-recombination-deficiency-signature-detects-homologous-recombination-deficiency-rna-patients-with-and-without-homologous-recombination-repair-gene-pathogenic-alterations-in-men-wi/ 2023-12-08T21:49:14+00:00 https://www.tempus.com/publications/genomic-characterization-of-vulvar-squamous-cell-carcinoma-reveals-differential-gene-expression-based-on-clinical-outcome/ 2023-12-18T18:48:16+00:00 https://www.tempus.com/news/tempus-announces-participation-in-national-cancer-institutes-combomatch-trials/ 2024-01-02T16:18:11+00:00 https://www.tempus.com/events/pmwc-2024/ 2024-01-02T17:53:06+00:00 https://www.tempus.com/publications/comparative-genomic-analysis-of-pik3r1-mutated-and-wild-type-breast-cancers/ 2024-01-03T16:21:13+00:00 https://www.tempus.com/resources/content/videos/tempus-presentation-at-the-2023-san-antonio-breast-cancer-symposium/ 2024-01-04T19:48:05+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Videos_SABCS-Product-Theatre.png https://www.tempus.com/news/tempus-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/ 2024-01-05T15:20:07+00:00 https://www.tempus.com/publications/private-payers-and-cancer-care-revisiting-the-land-of-opportunity/ 2024-01-08T21:59:11+00:00 https://www.tempus.com/publications/map2k1-mutated-melanocytic-tumors-have-reproducible-histopathologic-features-and-share-similarities-with-melanocytic-tumors-with-braf-v600e-mutations/ 2024-01-10T22:38:02+00:00 https://www.tempus.com/publications/the-landscape-of-somatic-genetic-alterations-in-breast-cancers-from-carriers-of-germline-pathogenic-variants-in-dna-repair-gene/ 2024-01-17T23:29:24+00:00 https://www.tempus.com/publications/real-world-clinical-genomics-study-of-hr-her2-metastatic-breast-cancers-treated-by-cdk4-6i-plus-endocrine-therapies-revealed-a-drug-resistant-tumor-segment-characterized-by-er-independence/ 2024-01-17T23:44:55+00:00 https://www.tempus.com/publications/breast-cancer-intrinsic-subtypes-predict-outcomes-in-primary-and-metastatic-samples/ 2024-01-17T23:45:34+00:00 https://www.tempus.com/publications/esr1-mutations-drive-resistance-to-cdk4-6-inhibitors-in-er-breast-cancer/ 2024-01-17T23:46:05+00:00 https://www.tempus.com/events/asco-gi-2024/ 2024-01-19T18:31:56+00:00 https://www.tempus.com/events/spatial-biology-for-immuno-oncology-summit-2024/ 2024-01-23T15:40:52+00:00 https://www.tempus.com/news/tempus-is-now-an-in-network-provider-for-humana-expanding-access-to-its-next-generation-sequencing-tests/ 2024-01-24T14:30:33+00:00 https://www.tempus.com/publications/phase-ii-dora-study-of-olaparib-with-or-without-durvalumab-as-a-chemotherapy-free-maintenance-strategy-in-platinum-pretreated-advanced-triple-negative-breast-cancer/ 2024-01-24T21:58:08+00:00 https://www.tempus.com/news/tempus-announces-medicare-coverage-for-tempusxt-across-solid-tumor-and-hematologic-malignancies/ 2024-01-26T16:21:14+00:00 https://www.tempus.com/publications/genomic-and-immune-landscape-of-biliary-tract-cancers-with-arid1a-pbrm1-and-bap1-alterations/ 2024-01-29T18:47:56+00:00 https://www.tempus.com/publications/impact-of-kras-codon-specific-mutations-on-survival-of-patients-with-metastatic-crc-mcrc-treated-with-trifluridine-tipiracil-tas-plus-bevacizumab-bev-a-real-world-analysis/ 2024-01-29T18:49:29+00:00 https://www.tempus.com/publications/a-tumor-uninformed-ctdna-assay-detecting-mrd-in-patients-with-resected-stage-ii-or-iii-colorectal-cancer-predicts-recurrence-subset-analysis-from-the-galaxy-study-in-circulate-japan/ 2024-01-29T19:12:19+00:00 https://www.tempus.com/publications/real-world-analyses-of-braf-alterations-in-patients-with-non-colorectal-gastrointestinal-cancers/ 2024-01-29T19:14:07+00:00 https://www.tempus.com/publications/prospective-evaluation-of-circulating-tumor-dna-using-next-generation-sequencing-as-a-biomarker-during-neoadjuvant-chemotherapy-in-localized-pancreatic-cancer/ 2024-01-30T17:21:54+00:00 https://www.tempus.com/publications/imputation-of-race-and-ethnicity-categories-using-genetic-ancestry-from-real-world-genomic-testing-data/ 2024-01-31T22:03:36+00:00 https://www.tempus.com/news/tempus-introduces-xm-to-assess-minimal-residual-disease-mrd-in-patients-with-colorectal-cancer-crc-for-research-use-only/ 2024-02-01T20:03:13+00:00 https://www.tempus.com/news/tempus-introduces-ai-enabled-assistant-tempus-one-into-lens-data-analytics-platform-to-accelerate-research/ 2024-02-02T14:30:29+00:00 https://www.tempus.com/publications/describing-the-genomic-landscape-of-bladder-cancer-histologic-subtypes/ 2024-02-02T17:26:10+00:00 https://www.tempus.com/publications/longitudinal-and-multi-tissue-molecular-diagnostics-track-somatic-brca2-reversion-mutations-that-correct-the-open-reading-frame-of-germline-alteration-upon-clinical-relapse/ 2024-02-07T16:10:54+00:00 https://www.tempus.com/news/tempus-announces-the-appointment-of-david-r-epstein-to-its-board-of-directors/ 2024-02-20T14:30:12+00:00 https://www.tempus.com/resources/content/case-studies/trihealth-achieved-9x-annual-enrollment-increase-with-tempus-time/ 2024-02-20T21:28:55+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-LS_Case-Study-Aadi-Bioscience.png https://www.tempus.com/news/tempus-expanding-access-to-its-next-generation-sequencing-tests-as-an-in-network-provider-for-cigna/ 2024-02-21T14:30:22+00:00 https://www.tempus.com/events/liquid-biopsy-for-precision-oncology-summit-2024/ 2024-02-20T22:16:13+00:00 https://www.tempus.com/events/ddr-inhibitors-summit-2024/ 2024-02-20T22:16:56+00:00 https://www.tempus.com/news/tempus-announces-new-ctdna-assay-xm-monitor/ 2024-03-06T22:23:41+00:00 https://www.tempus.com/publications/findings-from-the-friends-hrd-harmonization-project/ 2024-03-11T21:28:02+00:00 https://www.tempus.com/publications/characterizing-the-genomic-and-immune-landscape-of-serous-borderline-tumors-and-low-grade-serous-ovarian-cancer/ 2024-03-11T21:31:07+00:00 https://www.tempus.com/news/tempus-contributes-de-identified-cancer-data-to-planned-data-enclave/ 2024-03-14T13:30:52+00:00 https://www.tempus.com/publications/ancestry-inference-from-targeted-ngs-tests-to-enable-precision-medicine-and-improve-racial-ethnic-representation-in-clinical-trials-2/ 2024-03-18T17:27:14+00:00 https://www.tempus.com/publications/targeting-her2-her3-co-mutations-in-metastatic-breast-cancer-case-reports-of-exceptional-responders-to-trastuzumab-and-pertuzumab-therapy/ 2024-03-18T17:34:35+00:00 https://www.tempus.com/publications/evaluation-of-the-somatic-and-immunologic-landscapes-of-primary-and-metastatic-cervical-cancer-to-better-inform-future-clinical-trial-development/ 2024-03-20T19:45:02+00:00 https://www.tempus.com/publications/multimodal-real-world-data-reveals-immunogenomic-drivers-of-acquired-and-primary-resistance-to-immune-checkpoint-blockade-2/ 2024-03-22T20:25:58+00:00 https://www.tempus.com/news/tempus-announces-the-clinical-launch-of-p-msi-its-msi-high-predictive-algorithm-for-patients-with-prostate-cancer/ 2024-03-25T13:30:05+00:00 https://www.tempus.com/publications/molecular-profiling-of-advanced-non-small-cell-lung-cancer-in-response-to-first-line-immune-checkpoint-inhibitors-and-or-chemotherapy-using-multimodal-real-world-data/ 2024-03-22T20:45:24+00:00 https://www.tempus.com/publications/he-based-deep-learning-model-predicts-immune-phenotypes-in-nsclc/ 2024-03-25T21:00:14+00:00 https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.50.09-PM.png https://www.tempus.com/publications/robustness-of-deep-learning-histogenomic-models-to-tissue-area-tumor-purity-and-scanner-type/ 2024-03-25T21:04:15+00:00 https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.53.57-PM.png https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.54.06-PM.png https://www.tempus.com/publications/large-scale-dna-alteration-prediction-from-he-images-across-different-cancer-types-generalizing-to-external-images/ 2024-03-25T21:13:18+00:00 https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.03.01-PM.png https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.03.54-PM.png https://www.tempus.com/publications/pan-cancer-nuclei-segmentation-in-hematoxylin-and-eosin-whole-slide-images/ 2024-03-25T21:16:11+00:00 https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.11.48-PM.png https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-28-at-4.12.08-PM.png https://www.tempus.com/publications/time-savings-from-integrating-discrete-genomic-data-into-the-electronic-health-record-using-the-epic-aura-network/ 2024-03-26T22:39:18+00:00 https://www.tempus.com/news/tempus-announces-18-abstracts-accepted-for-presentation-at-the-american-association-for-cancer-research-annual-meeting-2024/ 2024-04-05T13:30:28+00:00 https://www.tempus.com/news/tempus-releases-new-data-at-aacr-showcasing-ways-to-analyze-multimodal-data-to-highlight-potential-therapeutic-routes-for-her2-directed-antibody-drug-conjugates-in-several-tumor-types/ 2024-04-08T13:30:45+00:00 https://www.tempus.com/news/tempus-introduces-workspaces-into-its-lens-data-analytics-platform/ 2024-04-06T13:30:27+00:00 https://www.tempus.com/publications/integration-of-patient-derived-tumor-organoids-and-patient-clinical-multimodal-data-to-investigate-the-role-of-organoids-in-predicting-treatment-response/ 2024-04-10T16:06:15+00:00 https://www.tempus.com/publications/deep-learning-enabled-dynamic-infiltration-and-response-to-nk-therapies-in-solid-tumor-organoids/ 2024-04-10T16:08:09+00:00 https://www.tempus.com/publications/identification-of-poor-responders-to-trastuzumab-deruxtecan-with-a-multi-modal-her2-status-predictor/ 2024-04-10T16:10:05+00:00 https://www.tempus.com/publications/genomic-characterization-of-vulvar-squamous-cell-carcinoma/ 2024-04-10T16:11:31+00:00 https://www.tempus.com/publications/early-stage-endometrioid-endometrial-cancer-recurrence-risk-stratification-using-a-machine-learning-rna-seq-gene-expression-signature/ 2024-04-10T16:25:25+00:00 https://www.tempus.com/publications/analysis-of-her2-prevalence-by-rna-expression-across-solid-tumors/ 2024-04-10T16:26:36+00:00 https://www.tempus.com/wp-content/uploads/2023/11/Screenshot-2023-11-29-at-3.13.14-PM.png https://www.tempus.com/publications/association-of-a-ctdna-biomarker-of-treatment-response-with-clinical-outcomes-in-a-real-world-pan-cancer-cohort-treated-with-tyrosine-kinase-inhibitors/ 2024-04-10T16:28:13+00:00 https://www.tempus.com/publications/robust-single-sample-consensus-molecular-subtype-classification-for-primary-and-metastatic-colorectal-cancer/ 2024-04-10T16:29:39+00:00 https://www.tempus.com/publications/molecular-characterization-of-resistance-to-immune-checkpoint-inhibitor-and-chemotherapy-treatment-in-advanced-non-small-cell-lung-cancer/ 2024-04-10T16:31:50+00:00 https://www.tempus.com/publications/profiling-the-splicing-landscape-in-solid-tumors-in-a-large-real-world-dataset/ 2024-04-10T16:36:14+00:00 https://www.tempus.com/publications/a-circulating-tumor-fraction-dna-biomarker-response-stratified-by-esr1-mutation-status-correlates-with-overall-survival-in-patients-with-hr-her2-metastatic-breast-cancer/ 2024-04-10T16:38:23+00:00 https://www.tempus.com/publications/a-novel-combination-of-tissue-informed-comprehensive-genomic-profiling-cgp-and-non-bespoke-blood-based-profiling-for-quantifying-circulating-tumor-dna-ctdna/ 2024-04-10T16:39:47+00:00 https://www.tempus.com/publications/real-world-validation-of-the-purist-classifier-demonstrates-enhanced-therapy-selection-for-pancreatic-ductal-adenocarcinoma-pdac-patients/ 2024-04-10T16:41:16+00:00 https://www.tempus.com/publications/leveraging-a-comprehensive-genomic-data-library-for-detecting-clonal-hematopoiesis-in-liquid-biopsy/ 2024-04-10T16:43:07+00:00 https://www.tempus.com/publications/a-tumor-intrinsic-signature-involving-immunosuppression-via-mif-cd74-signaling-is-associated-with-overall-survival-in-ict-treated-lung-adenocarcinoma/ 2024-04-10T16:44:59+00:00 https://www.tempus.com/publications/genetic-ancestry-associations-with-prostate-adenocarcinoma-mutational-profiles-new-insights-from-a-diverse-5959-patient-real-world-cohort/ 2024-04-10T16:46:01+00:00 https://www.tempus.com/publications/genetic-ancestry-associations-with-pancreatic-cancer-mutational-profiles-from-a-diverse-9274-patient-real-world-cohort/ 2024-04-10T16:47:35+00:00 https://www.tempus.com/publications/molecular-characterization-of-microsatellite-stable-mss-colorectal-cancer-crc-patients-with-a-braf-v600e-mutation/ 2024-04-10T17:00:09+00:00 https://www.tempus.com/uncategorized/predictors-of-inpatient-cost-of-care-in-patients-with-cardiovascular-disease-enrolled-in-the-centers-for-medicare-and-medicaid-cms-bundled-payments-for-care-improvement-advanced-bpci-a-initiative/ 2024-04-10T18:50:32+00:00 https://www.tempus.com/publications/evolving-from-discrete-molecular-data-integrations-to-actionable-molecular-insights-within-the-electronic-health-record/ 2024-04-12T20:00:35+00:00 https://www.tempus.com/resources/content/videos/introducing-tempus-next-care-pathway-intelligence-solution/ 2024-04-15T18:19:04+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Tempus-videos_Elevate-Speaker-Highlight.jpg https://www.tempus.com/news/tempus-introduces-its-ai-enabled-care-pathway-intelligence-platform-tempus-next/ 2024-04-16T16:35:20+00:00 https://www.tempus.com/publications/survey-of-ctx-009-patient-selection-hypotheses-using-real-world-biliary-tract-cancer-data/ 2024-04-17T17:04:21+00:00 https://www.tempus.com/publications/a-phase-ii-randomized-double-blind-study-of-the-use-of-rucaparib-vs-placebo-maintenance-therapy-in-metastatic-and-recurrent-endometrial-cancer/ 2024-04-17T17:24:36+00:00 https://www.tempus.com/resources/content/videos/lung-cancer/ 2024-04-22T17:37:38+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-videos_Lung-Cancer.png https://www.tempus.com/publications/concurrent-tissue-and-circulating-tumor-dna-molecular-profiling-to-detect-guideline-based-targeted-mutations-in-a-multicancer-cohort/ 2024-04-22T17:38:04+00:00 https://www.tempus.com/publications/associations-between-multimodal-immune-biomarkers-and-clinical-outcomes-in-a-real-world-non-small-cell-lung-cancer-cohort/ 2024-04-22T17:38:24+00:00 https://www.tempus.com/publications/evolving-from-discrete-molecular-data-integrations-to-actionable-molecular-insights-within-the-electronic-health-record-2/ 2024-05-09T21:01:18+00:00 https://www.tempus.com/publications/prediction-of-met-overexpression-in-lung-adenocarcinoma-from-hematoxylin-and-eosin-images/ 2024-05-13T15:15:33+00:00 https://www.tempus.com/publications/genomic-and-immune-landscape-comparison-of-met-exon-14-skipping-and-met-amplified-non-small-cell-lung-cancer/ 2024-05-20T17:20:19+00:00 https://www.tempus.com/publications/a-novel-phenotyping-pipeline-to-improve-identification-of-patients-with-pulmonary-hypertension-in-electronic-health-records/ 2024-05-23T17:09:19+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g8973_1.png https://www.tempus.com/publications/ecg-based-machine-learning-model-identifies-patients-at-high-risk-for-incident-pulmonary-hypertension/ 2024-05-23T17:09:57+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g9120_1.jpg https://www.tempus.com/publications/structured-ehr-data-underestimates-prevalence-and-misses-large-proportions-of-patients-with-pulmonary-hypertension/ 2024-05-23T17:10:37+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g8974_1.jpg https://www.tempus.com/publications/real-world-rw-treatment-tx-patterns-sequencing-and-outcomes-in-us-patients-pts-with-locally-advanced-or-metastatic-urothelial-cancer-la-muc-treated-with-avelumab-first-line-maintenance-1lm/ 2024-05-23T21:06:58+00:00 https://www.tempus.com/publications/changes-in-non-small-cell-lung-cancer-nsclc-next-generation-sequencing-ngs-rates-after-electronic-health-record-ehr-integration-using-large-scale-multi-institutional-real-world-data/ 2024-05-23T21:17:16+00:00 https://www.tempus.com/publications/impact-of-exigent-research-networks-partnership-with-the-tempus-ai-time-program-on-the-screening-and-matching-of-patients-for-clinical-trials/ 2024-05-23T21:41:25+00:00 https://www.tempus.com/publications/use-of-a-deep-learning-model-on-he-slides-to-predict-nucleic-acid-yield-for-ngs-testing/ 2024-05-23T22:22:48+00:00 https://www.tempus.com/publications/prognostic-impact-of-brca-mutation-on-metastasis-free-survival-in-a-localized-locoregional-high-risk-real-world-prostate-cancer-population/ 2024-05-23T22:25:42+00:00 https://www.tempus.com/publications/quantifying-clinical-actionability-of-updated-tumor-profiling-reports-through-electronic-health-record-ehr-enabled-on-demand-ordering-and-resulting/ 2024-05-23T22:33:04+00:00 https://www.tempus.com/publications/in-silico-tumor-immune-microenvironment-time-analysis-of-non-small-cell-lung-cancer-nsclc-to-inform-clinical-development-of-cdr404-a-first-of-its-kind-mage-a4-targeted-t-cell-engager/ 2024-05-23T22:44:26+00:00 https://www.tempus.com/publications/mutational-analysis-of-cfdna-to-identify-predictive-biomarkers-in-previously-untreated-patients-with-metastatic-pancreatic-cancer-receiving-the-gsk-3-inhibitor-elraglusib-9-ing-41-in-combination-wit/ 2024-05-23T22:51:12+00:00 https://www.tempus.com/publications/impact-of-intratumor-heterogeneity-ith-on-survival-outcomes-in-patients-with-non-small-cell-lung-cancer-nsclc-with-high-tumor-mutational-burden-tmb-h/ 2024-05-23T23:01:22+00:00 https://www.tempus.com/publications/pharmacogenomic-insights-in-psychiatric-care-uncovering-novel-actionability-allele-specific-cyp2d6-copy-number-variation-and-phenoconversion-in-15000-patients-2/ 2024-05-24T19:25:30+00:00 https://www.tempus.com/news/tempus-exhibits-16-abstracts-at-the-2024-american-society-of-clinical-oncology-annual-meeting/ 2024-05-30T13:30:13+00:00 https://www.tempus.com/news/tempus-announces-the-clinical-launch-of-its-mrd-testing-portfolio/ 2024-05-31T13:30:48+00:00 https://www.tempus.com/news/tempus-announces-new-features-to-its-smart-physician-platform-hub/ 2024-06-03T13:30:53+00:00 https://www.tempus.com/news/tempus-introduces-new-her2-folr1-testing-solutions-to-support-personalized-patient-care/ 2024-06-02T13:30:31+00:00 https://www.tempus.com/news/tempus-announces-expansion-of-collaboration-with-astrazeneca-to-leverage-tempus-next-to-support-guideline-directed-biomarker-testing-in-nsclc/ 2024-06-01T13:30:36+00:00 https://www.tempus.com/publications/comparison-of-tumor-immune-microenvironments-times-between-primary-and-metastatic-sites-mets-in-triple-negative-breast-cancer-tnbc/ 2024-06-05T18:49:34+00:00 https://www.tempus.com/publications/characterization-of-dna-damage-repair-ddr-alterations-and-the-tumor-immune-microenvironment-time-in-advanced-non-small-cell-lung-cancer-nsclc/ 2024-06-05T18:51:40+00:00 https://www.tempus.com/publications/comparing-the-somatic-germline-and-immune-landscapes-of-upper-tract-urothelial-carcinoma-utuc-and-uc-of-the-bladder-ucb/ 2024-06-05T18:52:34+00:00 https://www.tempus.com/publications/cost-effectiveness-of-a-circulating-tumor-fraction-molecular-biomarker-for-treatment-response-monitoring/ 2024-06-05T18:53:38+00:00 https://www.tempus.com/publications/matched-tissue-and-circulating-tumor-dna-ctdna-analysis-in-renal-cell-carcinoma-rcc-results-from-a-multimodal-real-world-database/ 2024-06-05T19:03:01+00:00 https://www.tempus.com/publications/relationship-between-dynamic-changes-in-circulating-tumor-fraction-and-real-world-imaging-with-real-world-survival-in-patients-with-solid-tumors-treated-with-immunotherapy/ 2024-06-05T19:39:18+00:00 https://www.tempus.com/publications/trihealth-cancer-institutes-collaboration-with-the-tempus-ai-time-program-impact-on-clinical-trial-operations-and-enrollment/ 2024-06-05T19:40:32+00:00 https://www.tempus.com/publications/clinicopathologic-and-molecular-landscape-of-invasive-mucinous-adenocarcinoma-of-the-lung/ 2024-06-05T19:41:44+00:00 https://www.tempus.com/publications/prognostic-value-of-portec-3-molecular-markers-by-disease-risk-in-a-real-world-early-endometrial-cancer-cohort/ 2024-06-05T19:43:12+00:00 https://www.tempus.com/resources/content/case-studies/identifying-patients-with-valvular-heart-disease-a-partnership-between-st-francis-and-tempus/ 2024-06-07T18:22:25+00:00 https://www.tempus.com/wp-content/uploads/2024/06/Case-Study_Next-Cardio-St.Francis.jpg https://www.tempus.com/publications/everest-2-a-seamless-phase-1-2-study-of-a2b694-a-mesothelin-msln-logic-gated-tmod-car-t-cell-therapy-in-patients-with-solid-tumors-that-show-msln-expression-and-human-leukocyte-antigen-hla-a02/ 2024-06-13T16:25:40+00:00 https://www.tempus.com/publications/everest-1-a-seamless-phase-1-2-study-of-a2b530-a-carcinoembryonic-antigen-cea-logic-gated-tmod-car-t-cell-therapy-in-patients-with-solid-tumors-associated-with-cea-expression-also-exhibiting-huma/ 2024-06-13T16:27:06+00:00 https://www.tempus.com/publications/improving-ethnic-and-racial-diversity-in-biomarker-driven-clinical-trials-a-proof-of-concept-with-the-basecamp-1-master-prescreening-study-of-patients-with-high-risk-solid-tumors-with-human-leukocyte/ 2024-06-13T16:30:32+00:00 https://www.tempus.com/news/pr/tempus-announces-pricing-of-initial-public-offering/ 2024-06-13T22:16:26+00:00 https://www.tempus.com/news/media-coverage/cnbc-4/ 2024-06-20T15:09:34+00:00 https://www.tempus.com/publications/reclassification-of-a-spindle-cell-sarcoma-after-identification-of-a-tfg-ros1-fusion-a-case-demonstrating-the-clinical-benefit-of-next-generation-sequencing-in-sarcoma/ 2024-06-21T16:48:36+00:00 https://www.tempus.com/news/tempus-announces-collaboration-with-united-therapeutics-to-study-use-of-ai-to-detect-patients-at-risk-for-pulmonary-hypertension/ 2024-06-25T13:30:36+00:00 https://www.tempus.com/news/tempus-receives-u-s-fda-510k-clearance-for-tempus-ecg-af-an-ai-based-algorithm-that-identifies-patients-at-increased-risk-of-afib/ 2024-06-26T13:30:56+00:00 https://www.tempus.com/events/tumor-models-boston-summit-2024/ 2024-06-28T20:01:54+00:00 https://www.tempus.com/news/cms-awards-tempus-with-advanced-diagnostic-laboratory-test-adlt-status-for-its-xt-cdx-test/ 2024-07-02T13:30:20+00:00 https://www.tempus.com/publications/natural-language-processing-optimized-case-selection-for-real-world-evidence-studies/ 2024-07-03T20:55:29+00:00 https://www.tempus.com/publications/comparative-analysis-of-microsatellite-instability-high-msi-h-braf-v600e-mutated-versus-msi-h-brafwild-type-colorectal-cancers-crc-including-tumor-microenvironment-tme-associated-genom/ 2024-07-03T20:57:47+00:00 https://www.tempus.com/publications/ptch1-and-axin2-modulation-of-ar-copy-number-effects-on-ar-gene-overexpression-in-metastatic-castration-resistant-prostate-cancer-mcrpc/ 2024-07-03T21:01:56+00:00 https://www.tempus.com/publications/mouse-intraductal-mind-an-in-vivo-model-for-studying-the-underlying-mechanisms-of-dcis-malignancy-2/ 2024-07-03T22:14:17+00:00 https://www.tempus.com/publications/deep-multimodal-fusion-for-the-discovery-of-prognostic-biomarkers-integrating-radiology-histology-and-molecular-information/ 2024-07-03T22:34:10+00:00 https://www.tempus.com/news/american-medical-association-grants-pla-code-to-tempus-algorithmic-test-purist/ 2024-07-08T14:29:05+00:00 https://www.tempus.com/news/tempus-surpasses-500-research-publications/ 2024-07-10T13:30:20+00:00 https://www.tempus.com/publications/a-phase-2-single-arm-study-of-nivolumab-and-ipilimumab-nivo-ipi-in-previously-treated-classical-kaposi-sarcoma-cks/ 2024-07-08T21:21:02+00:00 https://www.tempus.com/publications/frequency-of-common-and-uncommon-braf-alterations-among-colorectal-and-non-colorectal-gastrointestinal-malignancies/ 2024-07-10T22:09:43+00:00 https://www.tempus.com/publications/noninterventional-cohort-study-of-biomarker-testing-and-treatment-patterns-in-patients-with-advanced-gastric-or-gastroesophageal-junction-g-gej-cancer/ 2024-07-15T19:48:12+00:00 https://www.tempus.com/wp-content/uploads/2024/06/Screenshot-2024-07-01-at-2.18.41-PM.png https://www.tempus.com/resources/content/case-studies/revolutionizing-cardiac-care-ai-driven-detection-and-treatment-of-critical-heart-valve-disease-at-boulder-community-health/ 2024-07-15T19:48:38+00:00 https://www.tempus.com/wp-content/uploads/2024/06/Case-Study_Boulder-Community-Health.jpg https://www.tempus.com/news/tempus-expands-immuno-oncology-portfolio-with-launch-of-ai-enabled-multimodal-immune-profile-algorithmic-tests/ 2024-07-16T13:30:14+00:00 https://www.tempus.com/news/tempus-to-report-second-quarter-2024-financial-results-on-august-6/ 2024-07-17T13:30:01+00:00 https://www.tempus.com/resources/content/videos/embracing-ai-in-oncology-a-fireside-chat-with-industry-leaders-at-aacr/ 2024-07-17T17:55:26+00:00 https://www.tempus.com/wp-content/uploads/2024/06/AACR-Fireside-2024.png https://www.tempus.com/resources/content/videos/tempus-innovation-theater-presentation-from-the-2023-rsna-annual-meeting/ 2024-07-17T17:56:15+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Videos_SABCS-Product-Theatre.png https://www.tempus.com/news/mayo-clinic/ 2024-07-18T19:27:26+00:00 https://www.tempus.com/resources/content/articles/qa-grow-your-clinical-trial-portfolio-and-increase-enrollment-with-the-time-clinical-trial-network/ 2024-07-23T13:18:02+00:00 https://www.tempus.com/wp-content/uploads/2023/10/QA_-Grow-your-clinical-trial-portfolio-and-increase-enrollment-with-the-TIME-clinical-trial-network-thumb.jpg https://www.tempus.com/resources/content/articles/five-key-learnings-from-an-evidence-and-guidelines-based-application-of-pgx-in-mental-health/ 2024-07-23T13:20:15+00:00 https://www.tempus.com/wp-content/uploads/2023/10/Five-key-learnings-regarding-clinical-and-research-applications-of-liquid-biopsy-thumb.jpg https://www.tempus.com/resources/content/articles/accelerating-patient-enrollment-with-just-in-time-trials-trihealth-on-the-time-program/ 2024-07-23T13:25:50+00:00 https://www.tempus.com/wp-content/uploads/2023/07/Accelerating-patient-enrollment-with-just-in-time-trials_-TriHealth-on-the-TIME-program-thumb.jpg https://www.tempus.com/resources/content/articles/qa-the-evolution-of-rwd-in-heor-a-conversation-with-eisai/ 2024-07-23T13:26:49+00:00 https://www.tempus.com/wp-content/uploads/2023/07/QA_-The-evolution-of-RWE-HEOR%E2%80%94A-conversation-with-two-biopharmaceutical-executives-thumb.jpg https://www.tempus.com/resources/content/articles/qa-with-actuate-therapeutics/ 2024-07-23T13:29:39+00:00 https://www.tempus.com/wp-content/uploads/2023/06/QA_-Using-liquid-biopsies-%E2%80%A8to-build-CDx-in-pancreatic-cancer-with-Actuate-Therapeutics-thumb.jpg https://www.tempus.com/resources/content/articles/using-data-and-ai-ml-to-achieve-precision-medicine/ 2024-07-23T13:31:39+00:00 https://www.tempus.com/wp-content/uploads/2023/06/Using-data-and-AIML-to-achieve-precision-medicine-thumb.jpg https://www.tempus.com/resources/content/articles/validation-of-tempus-measurement-of-tumor-mutational-burden-using-real-world-data/ 2024-07-23T13:32:42+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Validation-of-Tempus-measurement-of-tumor-mutational-burden-using%E2%80%A8real-world-data-thumb.jpg https://www.tempus.com/resources/content/articles/using-multimodal-real-world-data-for-decision-making/ 2024-07-23T13:33:41+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Using-multimodal-real-world-data-for-decision-making-thumb.jpg https://www.tempus.com/resources/content/articles/qa-using-rwe-for-cdx-and-drug-development/ 2024-07-23T13:34:47+00:00 https://www.tempus.com/wp-content/uploads/2023/02/QA_-Using-RWE-for-CDx-and-drug-development-thumb.jpg https://www.tempus.com/resources/content/articles/use-multimodal-rwd-to-drive-breast-cancer-insights/ 2024-07-23T13:47:58+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Use-multimodal-RWD-to-drive-breast-cancer-insights-thumb.png https://www.tempus.com/resources/content/articles/qa-de-risking-clinical-trials-with-real-world-data/ 2024-07-23T13:48:51+00:00 https://www.tempus.com/wp-content/uploads/2023/01/QA_-De-risking-clinical-trials-with-real-world-data-thumb.jpg https://www.tempus.com/resources/content/articles/advancing-immuno-oncology-with-real-world-data/ 2024-07-23T13:49:49+00:00 https://www.tempus.com/wp-content/uploads/2022/12/Advancing-immuno-oncology-with-real-world-data-thumb.jpg https://www.tempus.com/resources/content/articles/cdx-and-cell-therapies-using-ngs-to-power-rd/ 2024-07-23T13:52:14+00:00 https://www.tempus.com/wp-content/uploads/2022/12/CDx-and-cell-therapies_-using-NGS-to-power-RD-thumb.jpg https://www.tempus.com/resources/content/articles/data-driven-companion-diagnostic-development/ 2024-07-23T13:53:00+00:00 https://www.tempus.com/wp-content/uploads/2022/11/Data-driven-companion-diagnostic-development-thumb.jpg https://www.tempus.com/resources/content/articles/how-to-use-rwd-for-good-with-najat-khan-phd/ 2024-07-23T13:54:23+00:00 https://www.tempus.com/wp-content/uploads/2022/10/How-to-use-RWD-for-good-with-Najat-Khan-Ph.D-thumb.jpg https://www.tempus.com/resources/content/articles/top-8-takeaways-from-the-esmo-congress-2022/ 2024-07-23T13:55:28+00:00 https://www.tempus.com/wp-content/uploads/2022/10/Top-8-takeaways-from-the-ESMO-Congress-2022-thumb.jpg https://www.tempus.com/resources/content/articles/the-promise-of-multimodal-real-world-data/ 2024-07-23T14:11:56+00:00 https://www.tempus.com/wp-content/uploads/2022/09/The-promise-of-multimodal-real-world-data-thumb.jpg https://www.tempus.com/resources/content/articles/navigating-biomarker-validation/ 2024-07-23T14:14:07+00:00 https://www.tempus.com/wp-content/uploads/2022/08/Navigating-biomarker-validation-thumb.jpg https://www.tempus.com/wp-content/uploads/2022/08/Figure-1v4.png https://www.tempus.com/resources/content/articles/getting-to-the-heart-of-multimodal-data/ 2024-07-23T14:14:41+00:00 https://www.tempus.com/wp-content/uploads/2022/08/Getting-to-the-heart-of-multimodal-data-thumb.jpg https://www.tempus.com/wp-content/uploads/2022/07/Figure-1_v4.1.png https://www.tempus.com/wp-content/uploads/2022/07/Figure-2_v4.png https://www.tempus.com/news/tempus-announces-expanded-data-and-sequencing-collaboration-with-remix-therapeutics-to-advance-novel-treatments/ 2024-07-30T12:30:14+00:00 https://www.tempus.com/publications/dynamic-changes-in-circulating-tumor-fraction-as-a-predictor-of-real-world-clinical-outcomes-in-solid-tumor-malignancy-patients-treated-with-immunotherapy/ 2024-07-29T21:34:17+00:00 https://www.tempus.com/news/tempus-next-launches-new-algorithm-to-close-care-gaps-in-guideline-directed-ihc-testing-starting-with-her2/ 2024-08-01T12:30:26+00:00 https://www.tempus.com/resources/content/case-studies/advancing-transcriptional-cancer-therapies-comprehensive-life-science-solutions/ 2024-07-31T15:24:23+00:00 https://www.tempus.com/wp-content/uploads/2024/06/Case-Study_Kronis-KB0742.jpg https://www.tempus.com/resources/content/articles/five-key-learnings-regarding-clinical-and-research-applications-of-liquid-biopsy/ 2024-07-31T15:25:22+00:00 https://www.tempus.com/wp-content/uploads/2023/10/Five-key-learnings-regarding-clinical-and-research-applications-of-liquid-biopsy-thumb.jpg https://www.tempus.com/resources/content/articles/the-value-of-rna-sequencing-in-drug-discovery/ 2024-07-31T15:25:49+00:00 https://www.tempus.com/wp-content/uploads/2023/08/The-value-of-RNA-sequencing-in-drug-discovery-thumb.png https://www.tempus.com/wp-content/uploads/2023/04/KRAS-Expression_KRAS-Mutation-Status.png https://www.tempus.com/wp-content/uploads/2023/08/PDL1-Expression_KRAS-Mutations.png https://www.tempus.com/wp-content/uploads/2023/04/TROP2-Expression_Tempus-Database.png https://www.tempus.com/wp-content/uploads/2023/08/MET-all-cancers.png https://www.tempus.com/wp-content/uploads/2023/08/Detection-Exon-Skipping-Events.png https://www.tempus.com/wp-content/uploads/2023/08/HER2-RNA-Expression_IHC-Results.png https://www.tempus.com/wp-content/uploads/2023/08/Lung-Adenocarcinoma_EGFR-Expression_Immune-Infiltration.png https://www.tempus.com/events/esmo-congress-2023/ 2024-07-31T19:17:10+00:00 https://www.tempus.com/events/aacr-annual-meeting-2024/ 2024-07-31T19:17:57+00:00 https://www.tempus.com/events/rsna-2023/ 2024-07-31T19:18:41+00:00 https://www.tempus.com/events/sabcs-2023/ 2024-07-31T19:19:08+00:00 https://www.tempus.com/events/aacr-2023/ 2024-07-31T19:19:55+00:00 https://www.tempus.com/publications/detecting-hla-loss-of-heterozygosity-within-a-standard-diagnostic-sequencing-workflow-for-prognostic-and-therapeutic-opportunities/ 2024-08-05T18:59:14+00:00 https://www.tempus.com/news/pr/tempus-reports-second-quarter-2024-results/ 2024-08-06T20:04:48+00:00 https://www.tempus.com/news/npj-precision-oncology-publishes-tempus-study-on-validation-of-its-hla-loh-investigational-assay/ 2024-08-08T12:30:01+00:00 https://www.tempus.com/events/asco-2024/ 2024-08-07T16:26:56+00:00 https://www.tempus.com/news/university-of-minnesota/ 2024-08-12T14:02:19+00:00 https://www.tempus.com/publications/accelerated-cardiac-magnetic-resonance-imaging-using-deep-learning-for-volumetric-assessment-in-children/ 2024-08-12T19:23:12+00:00 https://www.tempus.com/publications/a-comprehensive-analysis-of-pole-pold1-genomic-alterations-in-colorectal-cancer/ 2024-08-12T19:29:52+00:00 https://www.tempus.com/publications/predictors-of-disease-progression-and-adverse-clinical-outcomes-in-patients-with-moderate-aortic-stenosis-using-an-artificial-intelligence-based-software-platform/ 2024-08-12T19:36:12+00:00 https://www.tempus.com/publications/advancing-evidence-generation-for-circulating-tumor-dna-lessons-learned-from-a-multi-assay-study-of-baseline-circulating-tumor-dna-levels-across-cancer-types-and-stages/ 2024-08-12T19:48:35+00:00 https://www.tempus.com/publications/genetic-ancestry-and-somatic-mutations-in-lung-adenocarcinoma-insights-from-real-world-clinico-genomic-data/ 2024-08-12T19:53:26+00:00 https://www.tempus.com/publications/incorporating-real-world-clinico-genomic-insights-to-inform-diversity-enrollment-targets-in-oncology-trials/ 2024-08-12T19:58:56+00:00 https://www.tempus.com/publications/poly-adp-ribose-polymerase-inhibitors-parpi-therapy-response-in-an-acral-melanoma-patient-with-emsy-gene-amplification/ 2024-08-12T20:05:04+00:00 https://www.tempus.com/publications/development-and-validation-of-a-deep-learning-based-microsatellite-instability-predictor-from-prostate-cancer-whole-slide-images/ 2024-08-12T20:08:42+00:00 https://www.tempus.com/publications/a-diagnostic-dilemma-and-classification-conundrum-atypical-histiocytic-neoplasm-presenting-as-a-calvarial-mass/ 2024-08-12T20:21:41+00:00 https://www.tempus.com/publications/erbb3-overexpression-is-enriched-in-diverse-patient-populations-with-castration-sensitive-prostate-cancer-and-is-associated-with-a-unique-ar-activity-signature/ 2024-08-12T20:54:04+00:00 https://www.tempus.com/publications/pten-pathogenic-variants-are-associated-with-poor-prognosis-in-patients-with-advanced-soft-tissue-sarcoma/ 2024-08-12T21:08:12+00:00 https://www.tempus.com/publications/cancer-mutations-converge-on-a-collection-of-protein-assemblies-to-predict-resistance-to-replication-stress-2/ 2024-08-12T21:38:51+00:00 https://www.tempus.com/publications/a-comprehensive-analysis-of-clinical-and-polygenic-germline-influences-on-somatic-mutational-burden/ 2024-08-12T21:49:59+00:00 https://www.tempus.com/publications/pancreatic-cancer-action-networks-spark-a-cloud-based-patient-health-data-and-analytics-platform-for-pancreatic-cancer/ 2024-08-12T21:59:15+00:00 https://www.tempus.com/publications/association-of-genetic-ancestry-with-molecular-tumor-profiles-in-colorectal-cancer/ 2024-08-13T17:59:18+00:00 https://www.tempus.com/publications/comparison-of-tumor-immune-microenvironments-between-primary-and-metastatic-sites-in-non-small-cell-lung-cancer/ 2024-08-14T19:01:48+00:00 https://www.tempus.com/publications/tracheal-chondrosarcoma-a-novel-presentation-of-lynch-syndrome/ 2024-08-14T19:30:54+00:00 https://www.tempus.com/publications/advanced-age-in-humans-and-mouse-models-of-glioblastoma-show-decreased-survival-from-extratumoral-influence/ 2024-08-14T20:54:30+00:00 https://www.tempus.com/publications/pitfalls-in-machine-learning-based-assessment-of-tumor-infiltrating-lymphocytes-in-breast-cancer-a-report-of-the-international-immuno-oncology-biomarker-working-group-on-breast-cancer/ 2024-08-14T21:04:41+00:00 https://www.tempus.com/publications/neurofibromatosis-and-schwannomatosis-associated-tumors-approaches-to-genetic-testing-and-counseling-considerations/ 2024-08-14T21:08:48+00:00 https://www.tempus.com/publications/ancestry-driven-recalibration-of-tumor-mutational-burden-and-disparate-clinical-outcomes-in-response-to-immune-checkpoint-inhibitors/ 2024-08-14T21:20:01+00:00 https://www.tempus.com/publications/durable-clinical-response-to-the-multidisciplinary-management-of-neurosurgery-radiation-and-chemoimmunotherapy-in-a-patient-with-pd-l1-pd-l2-jak2-pdj-amplified-refractory-triple-negative-breast-ca/ 2024-08-14T21:31:06+00:00 https://www.tempus.com/publications/bloodpac-data-commons-for-liquid-biopsy-data/ 2024-08-14T21:39:48+00:00 https://www.tempus.com/publications/prolonged-response-to-treatment-based-on-cell-free-dna-analysis-and-molecular-profiling-in-three-patients-with-metastatic-cancer-a-case-series/ 2024-08-14T21:45:44+00:00 https://www.tempus.com/publications/preclinical-evaluation-of-artesunate-as-an-antineoplastic-agent-in-ovarian-cancer-treatment/ 2024-08-14T22:35:00+00:00 https://www.tempus.com/publications/specifications-of-the-acmg-amp-variant-interpretation-guidelines-for-germline-tp53-variants/ 2024-08-14T22:41:48+00:00 https://www.tempus.com/publications/first-in-human-phase-1b-trial-of-quinacrine-plus-capecitabine-in-patients-with-refractory-metastatic-colorectal-cancer/ 2024-08-16T14:48:10+00:00 https://www.tempus.com/publications/concordance-analysis-of-tissue-and-circulating-tumor-dna-ctdna-in-renal-cell-carcinoma-rcc-insights-from-a-multimodal-real-world-database/ 2024-08-19T18:31:16+00:00 https://www.tempus.com/publications/genetic-ancestry-associations-with-somatic-mutations-in-a-real-world-cohort-of-over-3000-patients-with-prostate-cancer/ 2024-08-19T19:28:51+00:00 https://www.tempus.com/publications/racial-and-genetic-ancestry-associations-with-gene-expression-patterns-in-a-real-world-cohort-of-colorectal-cancer-patients/ 2024-08-19T20:25:24+00:00 https://www.tempus.com/publications/exchanging-genomics-reports-between-pathology-labs-and-medical-centers-using-the-minimal-clinical-oncology-data-element-mcode-fhir-implementation-guide/ 2024-08-19T20:29:45+00:00 https://www.tempus.com/publications/fc%ce%b5ri%ce%b3-negative-nk-cells-and-association-with-improved-outcomes-in-trastuzumab-treated-patients/ 2024-08-19T20:34:25+00:00 https://www.tempus.com/publications/the-genomic-landscape-of-adolescent-and-young-adult-aya-malignancies-using-dna-and-rna-based-next-generation-sequencing/ 2024-08-19T20:38:23+00:00 https://www.tempus.com/publications/using-real-world-evidence-to-evaluate-broad-panel-vs-sequential-single-and-narrow-panel-sequencing-in-members-with-non-small-cell-lung-cancer-nsclc/ 2024-08-19T20:41:55+00:00 https://www.tempus.com/publications/pre-radiotherapy-ctdna-risk-stratifies-non-small-cell-lung-cancer-patients-with-oligometastatic-disease/ 2024-08-19T20:45:25+00:00 https://www.tempus.com/resources/content/videos/tempus-presentation-at-the-2024-asco-annual-meeting/ 2024-08-21T15:18:11+00:00 https://www.tempus.com/wp-content/uploads/2024/06/ASCO-IET-2024.png https://www.tempus.com/publications/longitudinal-clinical-performance-of-a-novel-tumor-naive-minimal-residual-disease-assay-in-patients-with-resected-stage-ii-and-iii-colorectal-cancer-a-subset-analysis-from-the-galaxy-study-in-circula/ 2024-08-21T15:18:31+00:00 https://www.tempus.com/publications/evaluating-the-clinical-significance-of-clonal-hematopoiesis-of-indeterminate-potential-chip-in-patients-with-non-small-cell-lung-cancer-nsclc/ 2024-08-21T18:34:04+00:00 https://www.tempus.com/publications/index-of-suspicion-predictors-of-tricuspid-regurgitation-progression-and-follow-up-echo-imaging-an-artificial-intelligence-enhanced-study/ 2024-08-21T19:36:56+00:00 https://www.tempus.com/events/world-cb-cdx-2024/ 2024-08-22T20:15:57+00:00 https://www.tempus.com/news/tempus-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference/ 2024-08-28T12:30:11+00:00 https://www.tempus.com/resources/content/articles/qa-the-evolving-role-of-antibody-drug-conjugates-in-oncology/ 2024-08-28T15:20:16+00:00 https://www.tempus.com/wp-content/uploads/2024/08/QA_-The-evolving-role-of-antibody-drug-conjugates-in-oncology.png https://www.tempus.com/publications/novel-associations-between-clonal-hematopoiesis-and-therapeutic-exposures-revealed-in-patients-with-solid-tumors-using-real-world-evidence/ 2024-08-28T17:42:22+00:00 https://www.tempus.com/publications/genetic-ancestry-associations-with-actionable-somatic-mutations-from-tumor-profiling-data-of-100000-cancer-patients/ 2024-08-28T19:29:38+00:00 https://www.tempus.com/events/wclc-2024/ 2024-09-03T16:18:24+00:00 https://www.tempus.com/news/tempus-announces-real-world-data-collaboration-with-biontech/ 2024-09-04T12:30:11+00:00 https://www.tempus.com/publications/development-of-machine-learning-models-for-prediction-of-left-ventricular-systolic-dysfunction-in-patients-with-isolated-left-ventricular-dilation/ 2024-09-04T16:36:22+00:00 https://www.tempus.com/resources/content/blog/building-the-ecg-of-the-future-with-artificial-intelligence/ 2024-09-05T14:37:22+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fornwalt-Cardiology.jpg https://www.tempus.com/events/ras-targeted-drug-development-summit-2024/ 2024-09-06T18:02:01+00:00 https://www.tempus.com/events/biotechx-usa-2024/ 2024-09-06T19:15:23+00:00 https://www.tempus.com/events/dpharm-2024/ 2024-09-09T15:46:03+00:00 https://www.tempus.com/resources/content/case-studies/personalized-depression-treatment-with-pharmacogenomic-testing/ 2024-09-10T13:42:56+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-LS_Case-Study-Aadi-Bioscience.png https://www.tempus.com/resources/content/videos/physician-testimonial-from-dr-neha-kansara-of-amen-clinic/ 2024-09-10T13:43:23+00:00 https://www.tempus.com/wp-content/uploads/2023/04/Tempus-videos_nP-Testimonial-Thumb.jpg https://www.tempus.com/resources/content/case-studies/pgx-case-for-adhd-patient-hypothetical/ 2024-09-10T13:44:10+00:00 https://www.tempus.com/wp-content/uploads/2022/12/PGx-Case-for-ADHD-Patient.png https://www.tempus.com/publications/molecular-and-immune-landscape-of-invasive-mucinous-adenocarcinoma-ima-of-the-lung-and-its-survival-outcome/ 2024-09-10T15:48:36+00:00 https://www.tempus.com/wp-content/uploads/2024/08/Screenshot-2024-08-14-at-2.22.56%E2%80%AFPM.png https://www.tempus.com/publications/concurrent-dna-and-rna-ngs-testing-to-characterize-rare-fusions-in-advanced-nsclc-patients/ 2024-09-10T15:50:28+00:00 https://www.tempus.com/publications/racial-differences-in-alk-gene-alterations-detected-by-tissue-and-liquid-biopsy-across-patients-with-lung-cancer/ 2024-09-10T15:51:26+00:00 https://www.tempus.com/publications/molecular-testing-care-gap-analysis-of-egfr-mutation-for-early-stage-nsclc-patients-in-community-practices/ 2024-09-10T15:52:44+00:00 https://www.tempus.com/news/pr/tempus-launches-beta-version-of-olivia-its-ai-enabled-personal-health-concierge-app-for-patients/ 2024-09-12T12:30:11+00:00 https://www.tempus.com/news/partnerships/henry-ford-health/ 2024-09-11T19:41:02+00:00 https://www.tempus.com/news/pr/tempus-announces-four-abstracts-accepted-for-presentation-at-the-european-society-for-medical-oncology-congress-2024/ 2024-09-13T12:30:49+00:00 https://www.tempus.com/publications/generalizability-of-radiomics-based-progression-risk-models-in-immunotherapy-treated-mnsclc-subjects/ 2024-09-13T15:27:10+00:00 https://www.tempus.com/events/esmo-congress-2024/ 2024-09-16T16:54:40+00:00 https://www.tempus.com/publications/the-association-of-changes-in-circulating-tumor-fraction-and-in-actionable-variant-allele-frequencies-with-clinical-outcomes-in-real-world-diverse-cohort-of-advanced-patients-treated-with-tyrosine-kin/ 2024-09-17T14:53:38+00:00 https://www.tempus.com/publications/impact-of-ras-and-brafv600e-mutations-on-tumor-immune-microenvironment-and-associated-genomic-alterations-in-patients-with-microsatellite-instability-msi-or-dna-mismatch-repair-deficient-dmmr-colo/ 2024-09-17T14:54:31+00:00 https://www.tempus.com/publications/impact-of-ai-clinical-trial-program-on-screening-matching-and-enrollment-of-patients-over-6-months/ 2024-09-17T14:55:26+00:00 https://www.tempus.com/publications/comprehensive-genomic-profiling-provides-patients-access-to-novel-matched-therapies-in-a-diverse-real-world-cohort-of-advanced-lung-cancer-patients/ 2024-09-17T15:17:43+00:00 https://www.tempus.com/events/nsgc-annual-conference-2024/ 2024-09-18T16:13:40+00:00 https://www.tempus.com/resources/content/articles/tempus-receives-fda-510k-clearance-for-tempus-ecg-af-an-ai-based-algorithm-that-identifies-patients-at-increased-risk-of-afib/ 2024-09-24T14:53:05+00:00 https://www.tempus.com/wp-content/uploads/2024/07/Tempus-Receives-U.S.-FDA-510k-Clearance-for-Tempus-ECG-AF-an-AI-based-Algorithm-that-Identifies-Patients-at-Increased-Risk-of-AFib2.png https://www.tempus.com/wp-content/uploads/2024/07/Brandon_Fornwaltbw.png https://www.tempus.com/wp-content/uploads/2024/07/John-Pfeiferbw.png https://www.tempus.com/news/tempus-announces-expansion-of-collaboration-with-takeda-to-leverage-multimodal-real-world-datasets-and-biological-model-systems-in-oncology-research-and-development/ 2024-09-26T12:30:01+00:00 https://www.tempus.com/resources/content/webinars/ai-algorithms-in-cardiology-navigating-the-path-from-research-to-practice/ 2024-09-25T19:50:54+00:00 https://www.tempus.com/wp-content/uploads/2024/09/UCLA-Health.png https://www.tempus.com/resources/content/webinars/enhancing-psychiatric-care-with-pharmacogenomics-pgx/ 2024-09-25T19:53:04+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/scientific-breakthroughs-across-the-cancer-continuum-research-from-the-2024-asco-annual-meeting/ 2024-09-25T19:54:02+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/integrating-omics-in-rd-a-new-era-of-biomedical-research/ 2024-09-26T13:36:45+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/harnessing-the-power-of-ai-optimizing-workflows-enhancing-testing-across-the-cancer-care-continuum/ 2024-09-26T13:38:04+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/adcs-in-focus-the-next-generation-of-precision-medicine-in-oncology/ 2024-09-26T13:39:11+00:00 https://www.tempus.com/wp-content/uploads/2024/06/MD-Anderson.png https://www.tempus.com/resources/content/webinars/liquid-biopsys-role-in-biomarker-driven-nsclc-management/ 2024-09-26T17:53:26+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Vanderbilt.png https://www.tempus.com/resources/content/webinars/leveraging-rna-sequencing-to-identify-actionable-biomarkers-in-nsclc-management/ 2024-09-26T17:55:11+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Ochsner-Health.png https://www.tempus.com/resources/content/webinars/unlocking-the-power-of-rna-in-drug-development/ 2024-09-26T17:56:30+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/evidence-guidelines-based-application-of-pgx-in-mental-health/ 2024-09-26T17:59:49+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/an-analysis-on-the-utility-of-liquid-biopsy-lbx-throughout-clinical-development/ 2024-09-26T18:02:14+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/accelerate-clinical-trial-enrollment-and-site-activation/ 2024-09-26T18:06:26+00:00 https://www.tempus.com/wp-content/uploads/2023/06/Tempus_Webinar_TriHealth.png https://www.tempus.com/resources/content/webinars/tempus-fda-approval-insights-use-companion-diagnostics-clinical-development/ 2024-09-26T18:08:03+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_nP-PGx.png https://www.tempus.com/resources/content/webinars/ngs-in-advanced-breast-cancer-exploring-recent-clinical-advancements/ 2024-09-26T18:08:56+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_nP-PGx.png https://www.tempus.com/resources/content/webinars/increasing-pts-using-multimodal-data/ 2024-09-26T18:10:01+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-webinar_AstraZeneca.png https://www.tempus.com/resources/content/webinars/multimodal-data-drives-biomarker-innovation/ 2024-09-26T18:10:57+00:00 https://www.tempus.com/wp-content/uploads/2022/12/Tempus-webinar_Gilead.png https://www.tempus.com/resources/content/webinars/evolving-standards-precision-medicine/ 2024-09-26T18:15:22+00:00 https://www.tempus.com/resources/content/webinars/personalized-mental-health-with-pharmacogenomics/ 2024-09-26T18:16:31+00:00 https://www.tempus.com/resources/content/webinars/the-next-evolution-in-drug-development/ 2024-09-26T18:17:22+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_Janssen.png https://www.tempus.com/resources/content/webinars/harnessing-real-world-genomics-data-to-power-precision-medicine/ 2024-09-26T18:19:04+00:00 https://www.tempus.com/resources/content/webinars/tempus-trihealth-epic-genomics-module/ 2024-09-26T18:20:02+00:00 https://www.tempus.com/wp-content/uploads/2021/11/Tempus_logoblack.png https://www.tempus.com/wp-content/uploads/2022/03/trihealth_logo.png https://www.tempus.com/resources/content/webinars/transforming-immunotherapy-with-tempus/ 2024-09-26T18:22:06+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_nP-PGx.png https://www.tempus.com/resources/content/webinars/optimizing-research-with-rwd-how-lens-accelerates-time-to-insights-in-drug-discovery/ 2024-10-01T13:57:10+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/impact-of-multimodal-data-in-translational-science/ 2024-10-01T14:04:44+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/articles/using-an-ai-algorithm-to-predict-possible-msi-high-status-in-prostate-cancer-patients-from-digital-pathology-images/ 2024-10-01T21:15:48+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Using-an-AI-algorithm-to-predict-possible-MSI-high-status-in-prostate-cancer-patients-from-digital-pathology-images-thumb.png https://www.tempus.com/events/biotechx-europe-2024/ 2024-10-02T18:05:51+00:00 https://www.tempus.com/resources/content/blog/meet-olivia/ 2024-10-09T13:16:27+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/news/partnerships/washington-university/ 2024-10-10T16:07:18+00:00 https://www.tempus.com/news/partnerships/oneoncology/ 2024-10-10T20:38:21+00:00 https://www.tempus.com/resources/content/case-studies/revolutionizing-drug-screening-with-tempus-ais-advanced-imaging-capabilities/ 2024-10-11T21:20:25+00:00 https://www.tempus.com/wp-content/uploads/2024/10/Case-Study_LS_AI-and-Drug-Screening.jpg https://www.tempus.com/resources/content/case-studies/enhance-your-clinical-development-process-with-tempus-cdx-platform/ 2024-10-17T15:42:05+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_A2-Biotherapeutics-with-CDx.jpg https://www.tempus.com/resources/content/articles/5-things-to-know-when-navigating-clinical-development-and-regulatory-pathways-for-cdx/ 2024-10-17T15:43:12+00:00 https://www.tempus.com/wp-content/uploads/2023/07/5-things-to-know-when-navigating-clinical-development-and-regulatory-pathways-for-CDx-thumb.jpg https://www.tempus.com/resources/content/webinars/precision-pathways-insights-strategies-to-navigate-regulatory-requirements-for-oncology-diagnostics/ 2024-10-18T21:07:02+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/tempus-io-overview/ 2024-10-23T18:46:12+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Content_Tempus-IO-Overview.jpg https://www.tempus.com/events/world-adc-2024/ 2024-10-24T18:33:42+00:00 https://www.tempus.com/news/tempus-announces-collaboration-with-jw-pharmaceutical-to-apply-real-world-data-and-biological-modeling-to-enhance-early-research-and-development/ 2024-10-28T12:30:38+00:00 https://www.tempus.com/publications/long-term-breast-cancer-response-to-cdk4-6-inhibition-defined-by-tp53-mediated-geroconversion/ 2024-10-25T20:50:38+00:00 https://www.tempus.com/resources/content/case-studies/reduce-time-to-launch-with-tempus-and-multimodal-data/ 2024-10-28T15:53:00+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_AstraZeneca-reduces-time-to-launch.jpg https://www.tempus.com/resources/content/case-studies/de-risk-investment-and-increase-the-probability-of-technical-success-pts-with-tempus/ 2024-10-28T16:02:05+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_AstraZeneca-increases-PTS.jpg https://www.tempus.com/resources/content/case-studies/make-quicker-decisions-by-simulating-and-contextualizing-data-with-tempus/ 2024-10-28T16:05:10+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Mirati-KRAS-G12C.jpg https://www.tempus.com/resources/content/case-studies/activate-trials-faster-with-the-time-program/ 2024-10-28T16:08:12+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Sermonix-TIME-Program.jpg https://www.tempus.com/resources/content/case-studies/make-critical-investment-decisions-using-tempus-vast-tumor-organoid-repository/ 2024-10-28T16:11:21+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Large-Biopharma.jpg https://www.tempus.com/resources/content/case-studies/closing-the-biomarker-testing-gap-for-early-stage-nsclc-patients-with-tempus-next/ 2024-10-28T16:24:15+00:00 https://www.tempus.com/wp-content/uploads/2024/10/Case-Study_NSCLC.jpg https://www.tempus.com/news/tempus-and-northwestern-medicine-announce-collaboration-to-bring-practical-application-of-ai-to-healthcare/ 2024-10-31T12:30:57+00:00 https://www.tempus.com/publications/unique-molecular-landscape-of-thyroid-cancer-in-african-americans-a-cross-institutional-large-cohort-genomic-analysis/ 2024-11-01T18:53:08+00:00 https://www.tempus.com/publications/onvansertib-in-combination-with-chemotherapy-and-bevacizumab-in-second-line-treatment-of-kras-mutant-metastatic-colorectal-cancer-a-single-arm-phase-ii-trial/ 2024-11-01T21:45:28+00:00 https://www.tempus.com/news/tempus-to-report-third-quarter-2024-financial-results-on-november-7/ 2024-11-04T00:42:39+00:00 https://www.tempus.com/publications/actionable-structural-variant-detection-via-rna-ngs-and-dna-ngs-in-patients-with-advanced-non-small-cell-lung-cancer/ 2024-11-04T16:40:57+00:00 https://www.tempus.com/news/pr/tempus-reports-third-quarter-2024-results-and-agreement-to-acquire-ambry-genetics/ 2024-11-04T21:01:44+00:00 https://www.tempus.com/publications/aspscr1tfe3-type-1-vs-type-2-fusions-in-alveolar-soft-part-sarcoma-asps-display-a-differential-tumor-immune-microenvironment-time-influencing-response-to-immune-checkpoint-inhibitors-icis/ 2024-11-05T19:33:55+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Screenshot-2024-11-05-at-1.32.43%E2%80%AFPM.png https://www.tempus.com/publications/impact-of-coverage-policy-complexity-and-restrictiveness-on-supportive-care-receipt-in-a-real-world-cohort-of-patients-with-cancer/ 2024-11-05T20:47:16+00:00 https://www.tempus.com/publications/uncovering-molecular-differences-in-pancreatic-ductal-adenocarcinoma-tissues-from-black-and-white-patients-in-the-us-2/ 2024-11-05T20:52:11+00:00 https://www.tempus.com/news/pr/tempus-announces-the-clinical-launch-of-its-immune-profile-score-algorithmic-test/ 2024-11-07T21:30:19+00:00 https://www.tempus.com/news/pr/tempus-announces-nine-abstracts-accepted-for-presentation-at-the-2024-society-for-immunotherapy-of-cancer-annual-meeting/ 2024-11-08T13:30:35+00:00 https://www.tempus.com/events/sitc-annual-meeting-2024/ 2024-11-08T16:11:38+00:00 https://www.tempus.com/news/pr/tempus-publishes-study-highlighting-benefits-of-concurrent-rna-and-dna-sequencing-in-advanced-cancer-care/ 2024-11-11T13:30:37+00:00 https://www.tempus.com/publications/intrinsic-subtype-distributions-across-inherited-breast-cancer-genes-an-opportunity-to-refine-treatment/ 2024-11-11T17:16:38+00:00 https://www.tempus.com/publications/variable-associations-between-humoral-immune-features-and-immune-checkpoint-blockade-related-outcomes-across-tissues-in-metastatic-lung-adenocarcinoma/ 2024-11-11T17:19:43+00:00 https://www.tempus.com/wp-content/uploads/2024/11/1-min.png https://www.tempus.com/wp-content/uploads/2024/11/2-min.png https://www.tempus.com/publications/self-supervised-representation-learning-enables-genomic-prediction-at-single-organoid-resolution/ 2024-11-11T17:23:56+00:00 https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A1387-F1.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A1387-F2.large_.jpg https://www.tempus.com/publications/pole-pold1-mutations-as-predictive-biomarkers-for-immunotherapy-response-insights-from-a-pan-cancer-real-world-dataset/ 2024-11-11T17:24:50+00:00 https://www.tempus.com/publications/clinical-validation-of-a-novel-multi-omic-algorithm-for-stratifying-outcomes-in-a-real-world-cohort-of-metastatic-solid-cancer-patients-treated-with-immune-checkpoint-inhibitors/ 2024-11-11T17:25:29+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Paper_7328_entryimage_686_0.png https://www.tempus.com/news/pr/tempus-molecular-profiling-integration-now-available-through-flatirons-oncoemr/ 2024-11-12T13:30:29+00:00 https://www.tempus.com/resources/content/articles/qa-using-ai-to-identify-and-close-gaps-in-care-for-cancer-patients/ 2024-11-14T17:11:46+00:00 https://www.tempus.com/wp-content/uploads/2024/06/QA_-Using-AI-to-Identify-and-Close-Gaps-in-Care-for-Cancer-Patients-thumb.png https://www.tempus.com/resources/content/articles/embracing-ai-in-oncology-a-fireside-chat-with-industry-leaders-at-aacr-2024/ 2024-11-14T19:58:02+00:00 https://www.tempus.com/wp-content/uploads/2024/05/Embracing-AI-in-Oncology_-A-Fireside-Chat-with-Industry-Leaders-at-AACR-2024-thumb.png https://www.tempus.com/resources/content/case-studies/pfizer-her2-expression/ 2024-11-14T23:04:39+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Pfizer-HER2-Expression.jpg https://www.tempus.com/resources/content/webinars/using-ai-to-identify-and-close-gaps-in-care-for-cancer-patients/ 2024-11-15T22:26:25+00:00 https://www.tempus.com/wp-content/uploads/2023/06/Tempus_Webinar_TriHealth.png https://www.tempus.com/publications/digital-profiling-of-gene-expression-from-histology-images-with-linearized-attention/ 2024-11-18T22:29:49+00:00 https://www.tempus.com/publications/pd-1-blockade-plus-cisplatin-based-chemotherapy-in-patients-with-small-cell-neuroendocrine-bladder-and-prostate-cancers/ 2024-11-18T23:24:55+00:00 https://www.tempus.com/tech-videos/tempus-os/introducing-tempus-os-a-new-era-in-precision-medicine/ 2024-11-20T16:26:32+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Tech-video-series-blog.jpg https://www.tempus.com/news/partnerships/university-of-washington/ 2024-11-20T16:44:50+00:00 https://www.tempus.com/publications/integrated-transcriptomic-analysis-of-cicdux4-fusion-sarcomas-reveals-elevated-proliferation-signaling-and-implicates-dna-repair-gene-pole/ 2024-11-20T16:55:05+00:00 https://www.tempus.com/wp-content/uploads/2024/11/ctos.png https://www.tempus.com/publications/everest-2-a-seamless-phase-1-2-study-of-a2b694-a-logic-gated-tmod-car-t-cell-therapy-in-patients-with-mesothelin-expressing-solid-tumors-with-human-leukocyte-antigen-a02-loss-of-heterozygosity/ 2024-11-20T17:25:13+00:00 https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A721-F1.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A721-F2.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A721-F3.large_.jpg https://www.tempus.com/publications/everest-1-initial-safety-data-from-a-seamless-phase-1-2-study-of-a2b530-a-logic-gated-tmod-car-t-cell-therapy-in-patients-with-solid-tumors-associated-with-cea-expression-also-exhibiting-hla-loh/ 2024-11-20T17:26:09+00:00 https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A670-F1.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A670-F2.large_.jpg https://www.tempus.com/publications/basecamp-1-is-an-efficient-pre-screening-study-that-identifies-patients-with-hla-loh-and-provides-mutational-rna-seq-and-microbiome-data-for-precision-logic-gated-car-t-therapeutic-trials/ 2024-11-20T17:33:48+00:00 https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A672-F1.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A672-F2.large_.jpg https://www.tempus.com/wp-content/uploads/2024/11/Screenshot-2024-11-20-at-11.31.43%E2%80%AFAM.png https://www.tempus.com/tech-videos/a-deep-dive-into-generative-ai-at-tempus/ 2024-11-21T01:22:51+00:00 https://www.tempus.com/tech-videos/the-magic-of-blocks-and-assemblies-in-agent-builder/ 2024-11-21T01:22:58+00:00 https://www.tempus.com/resources/content/case-studies/navigating-complex-cell-therapy-trials-with-compass-cro/ 2024-11-21T15:59:17+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Case-Study_Compass-Case-2-Navigating-Complex-Cell-Therapy.jpg https://www.tempus.com/resources/content/articles/qa-ai-algorithms-in-cardiology-from-research-to-clinical-practice/ 2024-11-21T16:00:46+00:00 https://www.tempus.com/wp-content/uploads/2024/11/QA_-AI-algorithms-in-cardiology_-from-research-to-clinical-practice.png https://www.tempus.com/resources/content/articles/qa-impact-of-multimodal-data-in-translational-science/ 2024-11-21T18:18:37+00:00 https://www.tempus.com/wp-content/uploads/2023/12/QA_-Impact-of-multimodal-data-in-translational-science-thumb.jpg https://www.tempus.com/resources/content/webinars/shaping-drug-development-with-tumor-organoids-and-rwd/ 2024-11-21T18:22:34+00:00 https://www.tempus.com/wp-content/uploads/2024/10/Nimbus-Therapeutics.png https://www.tempus.com/news/pr/tempus-to-participate-in-the-piper-sandler-36th-annual-healthcare-conference/ 2024-11-25T13:30:29+00:00 https://www.tempus.com/resources/content/articles/qa-a-deep-dive-into-the-science-and-significance-of-tempus-immune-profile-score-ips/ 2024-11-25T18:12:50+00:00 https://www.tempus.com/wp-content/uploads/2024/11/QA-A-deep-dive-into-the-science-and-significance-of-Tempus-Immune-Profile-Score-IPS.png https://www.tempus.com/resources/content/webinars/precision-outcomes-research-shaping-the-future-of-oncology-biopharma-with-real-world-evidence/ 2024-11-25T18:14:41+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/publications/low-level-aurora-kinase-a-aurka-amplification-as-a-novel-personalized-biomarker-of-cdk4-6-inhibitor-cdk4-6i-resistance-in-patients-with-hormone-receptor-positive-hr-metastatic-breast-cancer/ 2024-11-25T22:40:02+00:00 https://www.tempus.com/resources/content/case-studies/identifying-msi-high-in-prostate-cancer-using-ai-powered-digital-pathology/ 2024-11-26T17:36:58+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Case-Study_Identifying-MSI-High-in-Prostate-Cancer-Using-AI-Powered-Digital-Pathology.jpg https://www.tempus.com/resources/content/case-studies/maximizing-precision-in-pathology-the-critical-path-approach/ 2024-11-26T17:38:23+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Case-Study_Identifying-MSI-High-in-Prostate-Cancer-Using-AI-Powered-Digital-Pathology.jpg https://www.tempus.com/events/sabcs-2024/ 2024-11-27T17:25:10+00:00 https://www.tempus.com/publications/a-phase-ii-study-of-pembrolizumab-plus-fulvestrant-in-er-positive-her2-negative-advanced-metastatic-breast-cancer-patients/ 2024-11-27T19:21:15+00:00 https://www.tempus.com/publications/a-tumor-naive-ctdna-assay-detects-minimal-residual-disease-in-resected-stage-ii-or-iii-colorectal-cancer-and-predicts-recurrence-subset-analysis-from-the-galaxy-study-in-circulate-japan/ 2024-12-02T19:16:22+00:00 https://www.tempus.com/publications/precision-oncology-improvements-in-follow-up-and-confirmation-of-potential-germline-variants-identified-from-tumor-next-generation-sequencing/ 2024-12-04T16:45:16+00:00 https://www.tempus.com/publications/evaluation-of-real-world-tumor-response-derived-from-electronic-health-record-data-sources-a-feasibility-analysis-in-patients-with-metastatic-non-small-cell-lung-cancer-treated-with-chemother/ 2024-12-04T23:02:04+00:00 https://www.tempus.com/resources/content/articles/qa-advancing-immunotherapy-biomarker-identification-with-immune-profile-score-ips/ 2024-12-05T15:05:32+00:00 https://www.tempus.com/wp-content/uploads/2024/09/QA_-Advancing-immunotherapy-biomarker-identification-with-Immune-Profile-Score-IPS.png https://www.tempus.com/resources/content/immune-profile-score-ips-overview/ 2024-12-05T15:06:14+00:00 https://www.tempus.com/resources/content/webinars/advancing-io-therapeutics-the-convergence-of-novel-biomarkers-and-combination-strategies/ 2024-12-06T18:30:43+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/publications/optimizing-clinical-trial-subject-selection-insights-from-exigent-research-network-and-the-tempus-ai-time-program-collaboration/ 2024-12-06T19:40:42+00:00 https://www.tempus.com/publications/impact-of-timing-of-real-world-ct-imaging-on-cost-effectiveness-of-a-molecular-biomarker-for-treatment-response-monitoring-of-immunotherapy/ 2024-12-09T18:54:28+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Screenshot-2024-11-05-at-1.26.46%E2%80%AFPM.png https://www.tempus.com/wp-content/uploads/2024/11/Screenshot-2024-11-05-at-1.26.53%E2%80%AFPM.png https://www.tempus.com/wp-content/uploads/2024/11/jitc-2024-November-12-Suppl-2-A1514-F1.large_.jpg https://www.tempus.com/publications/circulating-tumor-dna-predicts-venous-thromboembolism-in-patients-with-cancers/ 2024-12-09T19:54:19+00:00 https://www.tempus.com/publications/calibrating-observational-health-record-data-against-a-randomized-trial/ 2024-12-09T20:03:22+00:00 https://www.tempus.com/news/pr/tempus-announces-four-abstracts-accepted-for-presentation-at-the-2024-san-antonio-breast-cancer-symposium/ 2024-12-10T13:30:13+00:00 https://www.tempus.com/resources/content/case-studies/an-algorithmic-approach-to-close-care-gaps-for-patients-that-may-benefit-from-confirmatory-ihc-her2-testing/ 2024-12-10T17:34:26+00:00 https://www.tempus.com/wp-content/uploads/2024/12/Case-Study_An-algorithmic-approach-to-close-care-gapsupdate.jpg https://www.tempus.com/publications/tremelimumab-and-durvalumab-as-neoadjuvant-or-non-operative-management-strategy-of-patients-with-microsatellite-instability-high-resectable-gastric-or-gastroesophageal-junction-adenocarcinoma-the-inf/ 2024-12-11T21:53:56+00:00 https://www.tempus.com/publications/identifying-fit-for-emulation-data-adaptation-of-a-structured-data-feasibility-assessment-process-for-real-world-oncology-trial-emulations/ 2024-12-11T22:10:56+00:00 https://www.tempus.com/publications/her2-expression-and-associated-real-world-overall-survival-rwos-in-patients-with-select-solid-tumors/ 2024-12-11T22:19:49+00:00 https://www.tempus.com/publications/a-comprehensive-whole-genome-sequencing-assay-provides-robust-characterization-of-clinically-relevant-genomic-alterations-across-myeloid-malignancies-concordant-with-matched-results-from-targeted-dna/ 2024-12-13T16:41:35+00:00 https://www.tempus.com/publications/characterization-of-the-tumor-immune-microenvironment-time-and-somatic-landscape-of-metaplastic-breast-cancer-mpbc/ 2024-12-16T17:40:50+00:00 https://www.tempus.com/publications/real-world-clinical-outcomes-of-patients-with-her2-brcam-early-breast-cancer-treated-with-adjuvant-capecitabine/ 2024-12-16T17:41:24+00:00 https://www.tempus.com/publications/economic-impact-of-concurrent-tissue-and-circulating-tumor-dna-molecular-profiling-in-advanced-breast-cancer-patients/ 2024-12-16T17:46:26+00:00 https://www.tempus.com/publications/real-world-comparative-efficacy-of-cdk4-6-inhibitors-in-first-line-treatment-of-hr-her2-metastatic-breast-cancer/ 2024-12-16T17:48:11+00:00 https://www.tempus.com/news/new-cms-decision-provides-medicare-coverage-for-the-clinical-use-of-the-tempus-ecg-af-device/ 2024-12-17T18:33:48+00:00 https://www.tempus.com/resources/content/white-papers/accelerating-adc-development-with-tempus-ai/ 2024-12-18T19:35:32+00:00 https://www.tempus.com/wp-content/uploads/2024/05/Case-Study_ADC-White-Paper.jpg https://www.tempus.com/resources/content/white-papers/real-world-data-on-measurement-based-care-with-tempus-pro/ 2024-12-18T19:36:13+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus-case-study_PRO-White-Paper.png https://www.tempus.com/news/tempus-now-an-in-network-provider-for-blue-cross-blue-shield-illinois-blue-shield-california-and-more/ 2024-12-19T01:38:28+00:00 https://www.tempus.com/publications/characterizing-genomic-variants-defining-a-plasma-cell-disorder-patient-cohort-using-a-broad-next-generation-multi-gene-dna-sequencing-panel/ 2024-12-23T20:56:01+00:00 https://www.tempus.com/publications/circulating-tumor-dna-predicts-venous-thromboembolism-in-minority-patients-with-cancers/ 2024-12-23T20:59:04+00:00 https://www.tempus.com/publications/loss-of-stk11-suppresses-lipid-metabolism-to-attenuate-kras-induced-immunogenicity-in-patients-with-non-small-cell-lung-cancer/ 2024-12-23T21:06:53+00:00 https://www.tempus.com/publications/genetic-ancestry-inference-from-tumor-profiling-data-of-100000-cancer-patients/ 2024-12-23T21:10:58+00:00 https://www.tempus.com/events/pmwc-2025/ 2025-01-02T17:38:33+00:00 https://www.tempus.com/news/media-coverage/softbank-group/ 2025-01-03T18:35:14+00:00 https://www.tempus.com/news/media-coverage/2024-forbes-healthcare-summit/ 2025-01-03T22:39:51+00:00 https://www.tempus.com/tech-videos/avoiding-the-pitfalls-of-rag-by-optimizing-llms-for-precision/ 2025-01-06T14:37:21+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Tech-video-series-blog.jpg https://www.tempus.com/tech-videos/tempus-os/innovations-from-tempus-in-clinical-insights-and-decision-support/ 2025-01-06T14:37:51+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Tech-video-series-blog.jpg https://www.tempus.com/tech-videos/generative-ai/simplifying-complex-queries-with-lens-cohort-builder/ 2025-01-06T15:04:37+00:00 https://www.tempus.com/wp-content/uploads/2024/03/lens-v2-01.jpeg https://www.tempus.com/news/tempus-announces-a-collaboration-with-genialis-to-develop-rna-based-biomarker-algorithms/ 2025-01-08T13:30:19+00:00 https://www.tempus.com/news/tempus-to-present-at-43rd-annual-j-p-morgan-healthcare-conference/ 2025-01-08T15:44:15+00:00 https://www.tempus.com/publications/development-and-validation-of-the-immune-profile-score-ips-a-novel-multi-omic-algorithmic-assay-for-stratifying-outcomes-in-a-real-world-cohort-of-advanced-solid-cancer-patients-treated-with-immune/ 2025-01-08T23:13:51+00:00